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Abbreviations： 
 Ti                 Titanium    
 Ni                Nickel   
 Cr                     Chromium   
 Fe                 Iron 
 Mo                    Molybdenum  
NiTi                    Nickel Titanium 
Ti-NPs               Titanium nanoparticles 
Ti-MPs            Titanium microparticles  
NiTi-MPs           Nickel Titanium microparticles  
NPs                    nanoparticles 
hTERT                human telomerase reverse transcriptase  
PDL                    periodontal ligament  
ICP-OES            inductively coupled plasma optical emission spectrometry  
LA-ICP-MS         laser ablation-inductively coupled plasma-mass spectrometry  
SEM                  scanning electron microscope 
EDX                    energy dispersive X-ray  
EC50                             half-maximum effect concentration 
PBS                    phosphate buffered saline 
LSCM                 laser scanning confocal microscopy 
TEM                   transmission electron microscopy  
OTM                   olive tail moment  
SiTi                     Silica-Titania Hollow  
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1 Introduction 
1.1 Analysis of Ti and other metals in human jawbones with dental implants 
Ti and its alloys have been widely used for dental and medical applications in the last 50 
years [1, 2]. Clinically, pure Ti (Ti >99%) and the alloy Ti-6Al-4V are mainly used for 
endosseous implants [2]. Ti alloys with other metals (e.g. Ni, Cr, Fe and Mo) are applied for 
implant devices such as bone plates or screws [2, 3]. Ti becomes the mainly used 
component in those implants/implant devices, since the stable TiO2 layer [4, 5] formed on the 
surface can provide Ti based implants/implant devices with high biocompatibility and 
resistance to corrosion [6-9]. 
Although Ti based implants are considered to be biologically inert, it has been found that 
implants in the body can undergo corrosion and release particulate debris over time [10, 11]. 
It has also been reported that the metallic debris from Ti based implants might exist in 
several forms including particles (micrometre to nanometre size), colloidal and ionic forms 
(e.g. specific/unspecific protein binding) [12, 13], organic storage forms (e.g. hemosiderin, 
which is an iron-storage complex), inorganic metal oxides and salts [12]. According to a 
previous study [14], the degradation of implants in the human body is primarily induced by 
wear and corrosion: wear is the mechanical/physical form of implant degradation which 
produces particles; while corrosion refers to the chemical/electrochemical form of 
degradation that mainly produces soluble metal ions [14]. Ti particles released from implants 
have been found in the regenerated bone and peri-implant tissues in animals [7, 15]. It has 
been shown that also Ti ions can be released from embedded implants in animals[16] [17]. Ti 
particles/ions are able to enter the circulation of blood and lymph [12, 18, 19]. Ti particles 
detached from hip, knee and mandible implants have been detected in organs such as liver, 
spleen, lung and lymph nodes [5, 19]. Increased levels of elementary Ti have also been 
detected in the blood of patients with poorly functioning implants [12].  
Increased concentrations of metals (e.g. Ti, Cr, Co and Al) derived from implants in body 
fluids might induce acute or chronic toxicological effects [12]. The long-term effects of Ti 
derived from implants are still not fully understood, but associated hypersensitivity and 
allergic reactions in patients have been reported [20, 21]. In a clinical study, 0.6% of 1500 
patients were found to exhibit Ti allergic reactions [20]. Additionally, it has been found that 
detached metal debris from implants might cause marrow fibrosis, necrosis and 
granulomatosis [22-24].  
Therefore, the release of Ti and other metallic elements in human body from dental implants 
should be concerned and measured. In our study, Ti content released from implants inserted 
into human jawbones was measured, Ti particles released to bone/bone marrow tissues 
were identified, and the spatial distribution of Ti in human jawbones near implants was also 
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investigated. This work was illustrated in the following publication: He X, Reichl FX, Wang 
Y, Michalke B, Milz S, Yang Y, Stolper P, Lindemaier G, Graw M, Hickel R, Högg C. Analysis 
of titanium and other metals in human jawbones with dental implants–A case series study.  
Dent  Mater. 2016; 32:1042-51.  
1.2 Intracellular uptake and toxicity of three different Ti particles 
Ti is preferentially used for endosseous dental implant material [2]. Besides Ti, some Ti 
alloys are also used for dental applications, such as NiTi. The alloy NiTi is used for castings 
of crowns and denture construction, orthodontic archwires and brackets [25, 26]. Recently it 
has been found that the properties of Ti implants can be improved by using nanostructured Ti 
consisting of Ti-NPs [27]. 
Even though Ti based implants are considered to be biocompatible, their induced side 
effects such as hypersensitivity and allergic reactions have been reported [20, 21, 28]. 
These side effects might have been caused by the interaction between tissues and implants 
[29, 30]. The released Ti ions and Ti particles can be transported and circulated in human 
bodies, and might also cause cytotoxic and genotoxic effects. The release of Ni ions from 
NiTi alloy also has been reported [26]. Previous studies indicated that Ti ions and Ni ions 
induced Cytotoxicity/DNA damage in human cells [31, 32]. Ti-particles/debris (0.5-250 µm) 
were found in the peri-implant animal tissues after the application of Ti based implants [7, 
15]. The toxic effects of Ti-particles have also been reported in previous literature: 
phagocytosis of Ti-particles could induce cytotoxicity in rat calvarial osteoblasts and MG63 
cells [33, 34]; Ti-particles also caused genotoxic effects, which induced apoptosis in 
mesenchym stem cells [35, 36].  
It was found that the toxicity of particles is related to the particle size and cellular uptake 
efficiency. The size-dependent toxicity of particles has been studied and conflicting results 
were found regarding the influence of the size of the particles on toxicity: nanoparticles, 
such as CuO-NPs and ZnO-NPs, induced higher cytotoxicity and genotoxicity than particles 
in micrometer size [37, 38]. In contrast to this, Fe2O3- , Fe3O4- and TiO2-NPs were found to 
be not more toxic than their corresponding micrometer-sized particles [37]. The ability of 
different particles to enter cells may also affect the toxicity [37-39], and the particle size can 
impact the cellular uptake efficiency and pathway [40]. 
Previous study indicated that cellular uptake efficiency of silica and gold nanoparticles was 
size-dependent [41, 42]. However, there is less data about the toxicity and cellular uptake 
efficiency for Ti particles with different size available. Since Ti particles can be released to 
human body from Ti-based implants, it would be of great sifnificance to find out the toxicity 
and cellular uptake of Ti particles in relation to particle size.  
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In order to compare the toxicity and cellular uptake of nanometre-sized Ti, micrometre-sized 
Ti and NiTi particles, which can be released from dental implants or replacements, Ti-NPs 
(Ti 98.5%, <100 nm), Ti-MPs (Ti 99%, <44 µm) and NiTi-MPs (Ni 30%, Ti 70%, < 44 µm) 
were investigated. The cytotoxicity, genotoxicity and cellular uptake efficiency of these 
investigated particles have been measured in PDL-hTERT cells. 
This work was published as follows: He X, Hartlieb E, Rothmund L, Waschke J, Wu X, Van 
Landuyt KL, Milz S, Michalke B, Hickel R, Reichl FX, Högg C. Intracellular uptake and toxicity 
of three different Titanium particles. Dent Mater. 2015 Jun; 31(6):734-44. 
 
2 Materials and methods 
2.1 Analysis of Ti and other metals in human jawbones with dental implants 
2.1.1 Materials 
The test group contained 7 samples from four human subjects with dental implants. The 
control group contained 6 bone samples from similar topographical regions from six human 
subjects without dental implants. 
Samples from human subjects I-III (samples 1-6) in the test group and all the samples in 
control group were obtained during the dissection course of the anatomical institute of 
Ludwig-Maximilian-University Munich. Sample from subject IV (sample 7) in test group was 
supplied by the institute of forensic medicine of Ludwig-Maximilian-University Munich.  
2.1.2 Sample analysis by ICP-OES 
2.1.2.1 Sample preparation 
All the samples had been fixed in 4% buffered formalin (Merck, Darmstadt, Germany). The 
soft tissue was cautiously removed and then immersed in 100% methanol. 
Test group 
Jawbone slices were prepared from samples 1-7 with a diamond band saw (cut-grinder 
macro, patho-service GmbH, Oststeinbek, Germany). The samples were cut at intervals of 1 
mm in a direction toward the implants, and cutting was stopped immediately adjacent to the 
implants. For analysis 5 jawbone slices closest to the implant were used. 
Each jawbone slice was further divided into 4 quadrants (A-D). Each quadrant was weighed 
and dissolved in 1 ml sub-boiled distilled nitric acid at 170ºC for 12 hours. The solution was 
subsequently diluted (1:5) and the contents of the elements Ti, Al, Cd, Cr, Co, Cu, Fe, Mn, 
Mo, Ni and V in each quadrant were analysed by ICP-OES (Optima 7300 DV, Perkin Elmer, 
Rodgau-Jügesheim, Germany).  
Control group 
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Control samples were taken from mandibular regions topographically comparable to those 
bearing the implants. For analysis by ICP-OES, same procedure as described for sample 1-7 
was performed.  
2.1.2.2 Analytical procedure 
Routinely after every ten measurements, three blank determinations and a control 
determination of a certified standard for all mentioned elements were performed. Calculation 
of results was carried out by relating the sample measurements to calibration curves, blank 
determinations, control standards and the weight of the digested sample. 
2.1.3 Spatial distribution measured by LA-ICP-MS 
2.1.3.1 Sample preparation  
The remaining parts of samples 4-7 (with higher Ti content compated to control) and control 
group were dehydrated in ascending ethanol fractions, defatted in xylenes (Merk, Darmstadt, 
Germany) and embedded in methylmethacrylate (Fluka, Switzerland).  
The polymerized methacrylate blocks were cut at a thickness of approximately 300 µm by a 
Leica SP 1600 saw-microtome (Leica, Wetzlar, Germany).  
The distribution of the isotopes 47Ti, 27Al, 43Ca, 52Cr, 59Co, 63Cu, 57Fe, 39K, 55Mn, 60Ni, 51V, 64Zn 
and 66Zn in each section was analysed by LA-ICP-MS-NWR-213® (New Wave Research Co. 
Ltd.) coupled to a NexION® 300 ICP-MS (PerkinElmer).  
2.1.3.2 Analytical procedure 
The laser ablations started from the bone region around 5mm from the implant and ended in 
the implant region.  
After the laser ablations, contact radiographs (Faxitron Xray Corporation, Lincolnshire, IL, 
USA) for each section were taken on Agfa Strukturix x-ray sensitive film (Agfa-Gevaert, 
Mortsel, Belgium). The laser lines were photographed with an Axiophot microscope (Zeiss, 
Goettingen, Germany), equipped with Zeiss Plan-Neofluar objectives (5× and 10×) in 
transmitted light mode.  
2.1.4 Histological analysis  
2.1.4.1 Sample preparation  
From each of the samples 4-7, one of the sections was glued (Cyanolit 201, Panacol LTD., 
Zürich, Switzerland) on opaque plastic slides, ground thinner, polished and stained with 
Giemsa-Eosin stain (Sigma Aldrich, Steinheim, Germany). The same procedure was applied 
for the control samples.  
2.1.4.2 Light microscopy observation and SEM-EDX measurements 
The stained sections were examined with an Axiophot microscope (Zeiss, Goettingen, 
Germany) that was equipped with Zeiss Plan-Neofluar objectives in transmitted light mode.  
The sections that contained visible dark particles were investigated with a SEM (EVO MA 15) 
(Zeiss, Goettingen, Germany) equipped with secondary electron (SE) and back-scattered 
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electron (BSE) detectors. The EDX analyses were performed using an Oxford INCA Penta 
Fetx (Oxford Instruments, England).  
The samples in control group were also histologically investigated and analysed by SEM-
EDX. 
2.2 Intracellular uptake and toxicity of three different Ti particles 
2.2.1 Particle size measurement 
Fresh stock solutions of Ti-MPs (Alfa Aesar, Karlsruhe, Germany), NiTi-MPs (Alfa Aesar, 
Karlsruhe, Germany) and Ti-NPs (Sigma–Aldrich, St. Louis, USA) were prepared by adding 
investigated particles (1000 mg Ti-MPs, 150 mg NiTi-MPs and 21.8 mg Ti-NPs) into 3 ml of 
medium and mixed. The particle size determination was performed with SEM LEO 1550 
(Zeiss, Oberkochen, Germany). 
2.2.2 Cytotoxicity  
By using XTT-based cell viability assay the EC50 values for the investigated particles were 
determined in PDL-hTERT cells. In this assay, 20000 cells/well were incubated for 24 h and 
treated with different concentrations of Ti-NPs, Ti-MPs and NiTi-MPs. Negative control and 
positive control cells received medium and 1% Triton X-100, respectively. After exposure 
with investigated particles for 24 h, 50 µl of the mixture of XTT labelling reagent and 
electron-coupling reagent in PBS was added into the cells as described by the manufacturer 
(cell proliferation kit II; Roche Diagnostics GmbH Penzberg, Germany) 4 h before 
photometric analysis.  
The cell viability was also measured by Trypan blue exclusion test. The cells were firstly 
treated with different concentrations of investigated particles for 24 h and then washed three 
times with PBS. Afterwards, the cells were detached and stained with 0.4% trypan blue 
(Sigma Aldrich, Steinheim, Germany) for 3 minutes. Ratio of dead cells in 100-120 cells was 
counted.  
2.2.3 DNA damage 
DNA damage of investigated particles was analysed by the alkaline single-cell microgel 
electrophoresis (comet assay) in red light.  
PDL-hTERT cells (2x105) were incubated in 1 ml medium for 24 h. Afterwards, the cells 
were exposed to different concentrations of investigated particles for 24 h. Then the cells 
were embedded in 75 µl LMP-Agarose (Sigma Aldrich, Steinheim, Germany) on the pre-
coated slide. The slide was then kept at 4 °C for at least 5 minutes, and another layer of
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 agarose was over stacked. After incubation at 4°C for 5 minutes, the covering glass was 
removed and the slide was stored in lysis buffer overnight.  
Before electrophoresis, the slides were placed in the alkaline electrophoresis solution (6°C) 
for 30 minutes. Electrophoresis was conducted at 6°C with 25 V, maximum 300 mA for 30 
minutes. The slides were then washed, stained with 200 µg/ml ethidium bromides (Sigma–
Aldrich, St. Louis, USA) and evaluated using an Olympus BX 60 fluorescence microscopy 
(Olympus, Hamburg, Germany) with a 40x objective. OTM was applied to evaluate DNA 
damage [43, 44]. 
2.2.4 Cellular uptake 
Cellular uptake of Ti-NPs, Ti-MPs and NiTi-MPs in PDL-hTERT cells was determined with 
LSM 510 (Zeiss, Oberkochen, Germany). The cells were incubated for 24 h on a covering 
glass and then exposed to Ti-NPs, NiTi-MPs and Ti-MPs at different concentrations for 
another 24 h. After that, the cells were stained with 2.5 µg/ml of Cell Mask Membrane 
Plasma Orange (Invitrogen, Oregon, USA). The cells were then fixed with 2% 
paraformaldehyde (Carl Roth, Karlsruhe, Germany) and stained with Sybr green I (1:50000) 
(Invitrogen, Oregon, USA). The covering glasses were mounted on microscopic slides using 
prolong gold anti-fade reagent with 4′, 6-diamidin-2-phenylindol (Invitrogen, Oregon, USA) 
and observed by LSM 510.  
TEM Libra 120 (Zeiss, Oberkochen, Germany) was used to confirm the cellular uptake of Ti-
NPs. Cells were treated with Ti-NPs (28 µg/ml) for 24 h, washed and fixed with 2% 
glutaraldehyde. The fixed cells were washed and then treated with 1% osmium tetroxide 
(Merck, Darmstadt, Germany). Dehydration was performed with ascending concentrations of 
ethanol: 30%, 50%, 70%, 90% and 100%. Afterwards, cells were embedded in epon 812 
(Serva, Heidelberg, Germany), after the resin blocks were hardened, they were cut into ultra-
thin sections (70-90 nm) with an ultra-microtome (Zeiss, Oberkochen, Germany), contrasted 
with 2% uranyl acetate followed by Pb-citrate and analysed by  TEM Libra 120. 
 
3 Results 
3.1 Analysis of Ti and other metals in human jawbones with dental implants 
3.1.1 Sample analysis by ICP-OES 
Among all the investigated elements (Ti, Al, Cd, Cr, Co, Cu, Fe, Mn, Mo, Ni and V), only the 
element Ti in the test group (samples 1-7) showed significantly higher content compared to 
the control group (p<0.05). 
The highest Ti content (13205 µg/kg-bone weight) of all total slices was detected in sample 6. 
The average Ti content across all 35 bone slices (n=35) of samples 1-7 (1940 ± 469 µg/kg-
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bone weight) was significantly higher compared to the average content across the 30 bone 
slices (n=30) from the control group (634±58 µg/kg-bone weight). 
There were no significant differences in Ti content averages between slices obtained at 
different distances from the implants. The Ti content of B quadrants (4510±1345 µg/kg-bone 
weight) was significantly higher compared to C (721±165 µg/kg-bone weight) and D (605±
98 µg/kg-bone weight) quadrants. Quadrant B in slice 2 of sample 6 showed the highest Ti 
content (37700 µg/kg-bone weight) compared to all the other single quadrants.  
The sum of the average Ti contents in the upper half of the bone slice - quadrants A+B (7064
±1932 µg/kg-bone weight) - is significantly higher compared to the sum of the average Ti 
contents in the lower half of bone slice - quadrants C+D (1327±256 µg/kg-bone weight). 
Within the control group there were no significant differences of the Ti contents calculated for 
all combinations of quadrants or slices. 
3.1.2 Distribution of isotopes measured by LA-ICP-MS 
The isotopes 47Ti, 27Al, 43Ca, 52Cr, 59Co, 63Cu, 57Fe, 39K, 55Mn, 60Ni, 51V, 64Zn and 66Zn in the 
bone slices with longitudinal cuts through the implants of samples 4-7 (which showed higher 
Ti content compared to control group measured by ICP-OES) were detected by LA-ICP-MS. 
47Ti was the only isotope of all investigated isotopes that could be detected in implant and 
human jawbone/jawbone marrow tissue of samples 4-7 (with implant) but not in the control 
samples without implants.  
For samples 4-7 along the ablation lines different intensities of 47Ti were detected. In sample 
4 the distribution of 47Ti along one ablation line showed that the average 47Ti intensity in a 
bone region within about 966 µm from the implant is 14 times higher compared to average 
value of bone at a distance >966 µm from the implant. Samples 5-7 also showed comparable 
results for 47Ti: increased intensities of 47Ti were also detected at distances of 556 -1587 µm 
to the implant surfaces. 47Ti can not only be found in the bone marrow tissues but also in the 
bone near the implant. 
3.1.3 Histological analyses  
The histological analysis was performed for samples 4-7 and the control group.  
Observation of samples 4-7 by light microscopy revealed black dots in the bone marrow 
tissues, which were identified as Ti particles by SEM-EDX analysis. Primary location of Ti 
particles was in the bone marrow tissue at a distance of 60-700 µm from the implant, with 
particle sizes < 40 µm. Multinucleated cells were found in the bone marrow tissues near 
implant. Our result also reveals traces of bone marrow fibrosis, an indication of previous 
inflammatory reactions. No Ti particles, no signs of fibrosis and no multinucleated cells were 
found in the control group. 
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SEM-EDX images showed that the particle size range of Ti particles is 0.5-5 µm (detection 
limitation of SEM for magnification factor used in present method is 0.5 µm). The result 
details for this section is shown in the first publication (7.1.1).  
3.2 Intracellular uptake and toxicity of three different Ti particles      
3.2.1 Particle size measurement 
About 90% of Ti-NPs were sized below 100 nm and 0.6% of Ti-NPs were sized above 200 
nm. Ti-MPs were sized between 0.3 µm and 43 µm; about 12% of Ti-MPs were below 1 µm, 
more than 50% of the particles were sized below 5 µm. NiTi-MPs were sized between 0.7 µm 
and 90 µm, 60% of the particles were sized above 10 µm and 17% of small particles were 
sized below 5 µm, only 4% of the small particles were below 1 µm. 
3.2.2 Cytotoxicity 
3.2.2.1 XTT viability assay 
Ti-NPs showed the highest toxic potential with an EC50 of 2.84±0.37 mg/ml (mean±SD, 
n=4). EC50 value of NiTi was 41.8±4 mg/ml (mean±SD, n=4). EC50 value for Ti-MPs could 
not be determined at the concentration <999 mg/ml and no higher concentrations of Ti-MPs 
were investigated. 
3.2.2.2 Cell death 
Ti-NPs caused 9% and 19% increase in cell death at the concentration of 284 µg/ml (1/10 
EC50, p<0.01) and 1420 µg/ml (1/2 EC50, p <0.001), compared to the medium (including 6% 
of dead cells). No significant difference for Ti-NPs was detected at the lower concentrations 
1/50 and 1/100 EC50, compared to medium.  
NiTi-MPs induced 9% more cell death (p<0.01) at the concentration of 20900 µg/ml (1/2 
EC50) compared to medium. No significant difference was found at 1/10 EC50, 1/50 EC50 and 
1/100 EC50.  
Ti-MPs only caused 9% increase (p<0.05) of dead cells at the highest concentration (33300 
µg/ml), compared to medium. No significant difference was found at lower concentrations.  
3.2.3 DNA damage  
After Ti-NPs exposure at all investigated concentrations, a significant increase in OTM 
value (compared to negative control) was detected (p<0.01). The mean OTM value for Ti-
NPs at 1/10 EC50 was significantly higher compared to 1/50 EC50, 1/100 EC50 and 1/200 
EC50 (p<0.01). There is no significant difference detected among 1/50 EC50, 1/100 EC50, 
and 1/200 EC50. A significant increase in OTM value (p<0.001) was observed at the 
concentration of 4180 µg/ml (1/10 EC50) after NiTi-MPs exposure compared to negative 
control. Ti-MPs induced a significant increase in OTM value (p<0.001) at the concentration 
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of 6666 µg/ml but no significant difference at the lower concentrations (3333 µg/ml, 666 
µg/ml and 333 µg/ml). 
In addition, the OTM value of Ti-NPs at the concentration of 284 µg/ml (1/10 EC50) was 1.5 
times higher than OTM value of NiTi-MPs at the concentration of 4180 µg/ml (1/10 EC50). 
284 µg/ml (1/10 EC50) of Ti-NPs induced a significantly higher OTM value compared to Ti-
MPs at 6666 µg/ml (p<0.001).  
3.2.4 Cellular uptake 
Ti-NPs could be detected in the cytoplasm and nucleus of PDL-hTERT cells, while for NiTi-
MPs and Ti-MPs, no particles were detected in the nucleus, particles around 1 µm were 
found in the PDL-hTERT cytoplasm. The ratio of cells with Ti-NPs inside the cytoplasm 
significantly increased (p<0.05) when the exposure concentration of Ti-NPs was raised. The 
ratio of cells with Ti-NPs in the nucleus also increased significantly from 5.0±1.5% (mean 
±SD, n=4) to 11%±1.3% (mean ± SD, n=4) when the exposure concentration was increased. 
For NiTi-MPs, no significant difference was found in the cellular uptake efficiency when the 
exposure concentration increased from 418 to 4180 µg/ml. For Ti-MPs (418 µg/ml), 
33%±4.5% (mean ± SD, n=4) of the detected cells were found with Ti-MPs in the cytoplasm. 
The cellular uptake of Ti-NPs in PDL-hTERT cells was confirmed with TEM. After exposure 
to 28 µg/ml (1/10 EC50) of Ti-NPs for 24 h, particles between 30 nm and 200 nm were 
detected inside the cytoplasm.  
 
4 Synopsis/ Zusammenfassung 
4.1 Synopsis 
In recent years, Ti is commonly used for dental implants [6] due to its high corrosion 
resistance, high biocompatibility, high strength and light weight. However, the animal studies 
indicated that Ti implant can release debris including particles and ions into the surrounding 
bone or bone marrow tissues [7, 15-17]. The released Ti species can even be circulated in 
blood and lymph [12, 18, 19]. Possible side effects (including bone marrow fibrosis, necrosis 
and allergic reactions) relating to Ti implants were also reported [20-23]. Therefore, it would 
be of great significance to find out whether the Ti-implants can induce health problems to 
human beings and how the Ti-implant causes the health problems.  
In the first study, Ti content released from dental implants in the human jawbones was 
measured, which can be taken as a reference for the risk assessment of Ti-implants in 
human. In this study, the level of released Ti from dental implants was determined by ICP-
OES, the distribution of Ti in human jawbone or bone marrow tissues was measured with LA-
ICP-MS, and the particles detached from dental implants were observed and identified with 
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light microscopy and SEM-EDX. The effect of released Ti particles on human tissues was 
also investigated with histological analysis. 
In the second study, the toxicity and cellular uptake of three kinds of Ti particles (NiTi-MPs, 
Ti-MPs and Ti-NPs) in PDL-hTERT cells were investigated. The toxicity of these Ti particles 
was measured by using XTT test and comet assay. Morever, the cellular uptake of the 
investigated particles in PDL-hTERT cells was also detected by LSCM and TEM, and with 
these results the ability of investigated particles to enter PDL-hTERT cells was investigated.  
By comparing the released Ti content detected in the first study and the EC50 of three 
investigated particles determined in the second study, a rough risk assessment was 
conducted. In the first study, Ti particles (0.5-5 µm) detached from dental implants were 
observed in the bone marrow tissues, and in the second study the cellular uptake of Ti 
particles with different sizes was determined, which might give a clue for the toxicity and 
transportation of Ti particles in human bone/ bone marrow tissues. 
4.1.1 Analysis of Ti and other metals in human jawbones with dental implants   
4.1.1.1 ICP-OES                                                                                                            
Among the analysed elements, only Ti showed significantly higher contents in the test group 
compared to the control group. The highest content detected in the test group was 37700 
µg/kg-bone weight. Our human jawbones were obtained from the forensic medicine and the 
anatomical insititution of LMU Munich.  Due to ethical considerations, it is not possible to give 
the detail information about these implants in test group, such as the “age” of the implants, 
the type of the implants, the method of surgeon and surface treatment of the implants and 
impurities present in the implant before insertion. But what we can be sure is that Ti implants 
can really release Ti species into the human bone, and among 35 slices from 7 samples in 
the test group, the highest Ti content is 37700 µg/kg-bone weight.  
4.1.1.2 LA-ICP-MS  
The distributions of 13 isotopes 47Ti, 27Al, 43Ca, 52Cr, 59Co, 63Cu, 57Fe, 39K, 55Mn, 60Ni, 51V, 
64Zn and 66Zn in bone samples 4-7 with implants were measured by LA-ICP-MS. In bone 
samples without implant no increased 47Ti was detected. Increased intensity of 47Ti for 
samples 4-7 was detected in the bone region adjacent to the implant (about 556-1587 µm 
away from the implant surface). And this indicated that Ti can migrate from the implant into 
the surrounding human jawbone or jawbone marrow tissues. In addition, the intensity of 47Ti 
increased with decreasing distance from the implants, which suggests that the distribution of 
47Ti in the jawbone depends on the distance from the implant. Interestingly, 47Ti is present not 
only in the peri-implant human jawbone marrow tissues but also in the cortical or trabecular 
bone matrix adjacent to the implant.  
4.1.1.3 Histological analyses  
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In the current study, SEM results showed Ti particles with a size of 0.5-5 µm in human 
jawbone marrow tissues. Clinical studies indicated that particles of Ti and Ti alloys ranging 
from 0.01 µm (10 nm) to 50 µm can be released into human body from Ti-based implants or 
replacements [19, 45] and the animal studies demonstrated the presence of Ti 
particles/debris sized between 3 µm and 250 µm in the peri-implant bone or tissues [7, 15]. 
The particle sizes of our investigated particles are in these reported ranges. Previous 
studies reported that particles <1 µm could be taken up by non-phagocytic eukaryotic cells 
via endocytosis [46] and particles with diameters exceeding 0.75 µm can be taken up by 
macrophages, neutrophils and monocytes via phagocytosis or through macropinocytosis 
(>1 µm) by all cell types [47]. Therefore, transportation of Ti particles with size of 0.5-5 µm 
observed in human bone marrow tissues of present study into cells is possible.  
Bone marrow fibrosis and multinucleated cells were observed near the implant in this study. 
Similarly, a previous post-mortem study about metal particles released from implants showed 
fibrosis in lymph-node [22]. Furthermore, multinucleated cells have been observed after 
hydroxyapatite implantation in rat periodontal tissues [48]. Bone marrow fibrosis might be 
induced by marrow injury and inflammation [49]. These effects are reported to be associated 
with surgical trauma during insertion of implants [50]. Multinucleated giant cells can be 
elicited by wear particles in periprosthetic tissues in human specimens and these cells might 
contain phagocytized wear particles [51]. Therefore, the observed bone marrow fibrosis and 
multinucleated giant cells might be associated with the dental implants.  
4.1.2 Intracellular uptake and toxicity of three different Ti particles 
In this study, the toxic potential of Ti-NPs, Ti-MPs and NiTi-MPs in PDL-hTERT cells was 
measured and compared according to their particle size and cellular uptake efficiency. 
4.1.2.1 Cytotoxicity: XTT assay and cell death  
It is previously reported that the cytotoxicity of NPs might have been induced by their large 
surface area per mass, release of toxic ions and ability to pass the cell membrane [38, 52]. In 
the present study, XTT test and trypan blue exclusion test were used to measure the 
cytotoxicity of Ti-NPs, Ti-MPs and NiTi-MPs in PDL-hTERT cells. The results of XTT test 
indicated that Ti-NPs induced higher cytotoxicity than Ti-MPs, which is also confirmed by the 
trypan blue exclusion test.  
Previous studies showed that Ti particles sized below 150 µm exhibited no cytotoxicity in 
human fibroblasts [53, 54], but 10 μg/ml of TiO2-NPs with a size of 30 nm could induce 40% 
reductions in the cell viabilities of human amnion epithelial cells [54]. In addition, our results 
indicated that the EC50 of Ti-MPs (<44 µm) in PDL-hTERT cells was above 999 mg/ml, while 
the EC50 of Ti-NPs with size between 20 nm and 250 nm was 2.84 mg/ml [55]. Regarding the 
highest Ti content (37700 µg/kg) detected in the human bones, a following calculation for a 
rough risk assessment was conducted: assuming that Ti in 1 kg bone corresponds to Ti in 1 
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L fluid, a maximal Ti concentration of 38 µg/ml can be calculated. Assuming it contains only 
Ti-NPs in this concentration, and we found that this value (38 µg/ml) is 74 times lower 
compared to the EC50 (2.84 mg/ml) of Ti NPs [55].  
4.1.2.2 DNA damage  
Comet assay was performed to determine the DNA damage caused by investigated Ti 
particles, which indicated that 14 µg/ml of Ti-NPs induced around 1.5-fold increase in OTM 
value compared to negative control in PDL-hTERT cells; while a 500 fold concentration 
(6666 µg/ml) was required for Ti-MPs to get the same extent of DNA damage with Ti-NPs. 
The increase in OTM value is considered to be an indicator of DNA damage [43, 44]; 
therefore, Ti-NPs displayed a 500-time higher DNA damage potential compared to Ti-MPs. 
On the contrary, in previous studies Fe2O3-NPs and TiO2-NPs  caused significantly (p<0.05) 
less DNA damage (5% less in tail) compared to the corresponding MPs at the same 
concentrations [37].
 
But it was also described that NPs of ZnO and CuO, induced more DNA 
damage than their corresponding MPs: ZnO-NPs induced a significant increase in DNA 
damage in human nasal mucosa cells starting from the concentration of 10 µg/ml (p<0.05), 
in comparison to the negative control, while no DNA damage was observed with ZnO-MPs 
at the same concentration [38]; a 4-h exposure to CuO-NPs induced 4 times more DNA 
damage in A549 cells at the concentration of 40 µg/cm2 compared to the control group, 
same concentration of CuO-MPs  only caused 0.5 fold more DNA damage [37].   
4.1.2.3 Cellular uptake  
Ti-NPs showed the highest cellular uptake efficiency but with smaller particle size, 
compared to Ti-MPs and NiTi-MPs, which indicates that the uptake of Ti particles in PDL-
hTERT cells is also size-dependent. This result for Ti-NPs is in line with previous studies. 
These former studies reported that non-phagocytic eukaryotic cells could take up particles 
that are below 1 µm [46], and the cellular uptake efficiency of nanoparticles can be affected 
by particle size [41, 42, 56]: smaller particles (in nanometre) could mediate higher cellular 
uptake than big particles in micrometre size.  
In the present study, in addition to the detected highest cellular uptake efficiency, the 
highest cytotoxicity was also determined for Ti-NPs, compared to Ti-MPs and NiTi-MPs. 
Similar result has been reported by a previous study, where toxicity of SiTi-NPs in 
macrophages has been correlated to the cellular uptake efficiency: cationic SiTi-NPs (50 nm) 
induced the highest uptake efficiency and also the most toxic effects (e.g. cytotoxicity) on 
macrophages J774A.1 cells compared to the other SiTi-NPs with different sizes and coating 
surfaces[39]. Therefore, our results indicated that the cellular uptake of Ti particles might 
correlate with the toxic effects on the cells, and a higher cellular uptake can cause more 
toxic effects. Furthermore, the results of the present study showed that only Ti-NPs were 
found in the nucleus and Ti-NPs induced more DNA damage compared to Ti-MPs and NiTi-
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MPs. So the higher potential of DNA damage for NPs might also be explained by the 
nuclear uptake of NPs. 
 
Conclusions: 
In this study, the highest content of Ti released from dental implants in human jawbones is 
37700 µg/kg-bone weight, which is more than 70 times lower than the EC50 of Ti-NPs in 
human PDL-hTERT cells. Ti particles  in size  between  0.5 µm  and 40 µm  were  observed  
in  the  jawbone marrow  tissues  near  the  implant,  which  might  induce  fibrosis  and  
multinucleated  cells in bone marrow tissues.  
Ti-NPs which have small particle size could induce higher cellular uptake and higher toxic 
effects compared to the other Ti particles. Therefore, it is suggested that the cellular uptake 
of Ti particles might induce toxic effects on human cells. According to the“worst case 
situation” risk assessment results, we  suggest  that  Ti  dental  implants  might  have  no 
adverse  effects in clinical use.  However, our study on human jawbones also indicated that 
the released Ti from dental implants is not totally inert.   
4.2 Zusammenfassung  
In letzter Zeit war Ti wegen seiner hohen Korrosionsfestigkeit, seiner hohen 
Biokompatibilität, seiner hohen Stabilität und seinem geringen Gewicht ein gebräuchliches 
Material für Zahnimplantate [6]. Jedoch zeigten Tierversuche das Ti-Implantate Fremdstoffe 
wie Partikel und Ionen in den umgebenden Knochen oder Knochenmark freisetzen können 
[7, 15-17]. Freigesetztes Titan kann sogar in Blut und Lymphe zirkulieren [12, 18, 19]. Über 
mögliche Nebenwirkungen in Verbindung mit Ti-Implantaten (Z.B. Knochenmarkfibrose, 
Nekrose und allergische Reaktionen) wurde berichtet [20-23]. Darum ist es von großer 
Bedeutung, herauszufinden ob Ti-Implantate Gesundheitsprobleme beim Menschen 
verursachen und wie das Ti-Implantat diese Probleme verursacht.  
In der ersten Studie wurde die vom Implantat im menschlichen Kieferknochen freigesetzte 
Menge an Titan gemessen, was als Grundlage für eine Risikobewertung von Ti-Implantaten 
im Menschen genutzt werden kann. Der Ti-Gehalt wurde mit ICP-OES, die Ti-Verteilung im 
humanen Kieferknochen und Knochenmark wurde mit LA-ICP-MS bestimmt. Die vom 
Implantat losgelösten Partikel wurden detektiert und identifiziert mit Lichtmikroskopie und 
SEM-EDX. Die Auswirkungen der freigesetzten Ti-Partikel auf das menschliche Gewebe 
wurden histologisch untersucht. 
In der Zweiten Studie wurden drei Arten von Ti-Partikeln (NiTi-MPs, Ti-MPs und Ti-NPs) an 
PDL-hTERT Zellen auf die Toxizität und die zelluläre Aufnahme untersucht. Die Toxizität 
der Partikel wurde mit dem XTT-Test und dem Comet Assay gemessen, die zelluläre 
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Partikelaufnahme wurde mit LSCM und TEM bestimmt und mit diesen Ergebnissen die 
Fähigkeit der Partikel zum Eindringen in PDL-hTERT Zellen untersucht.  
Durch Vergleich der freigesetzten Ti-Menge aus Studie eins mit den EC50-Werten der drei 
untersuchten Partikelarten aus Studie zwei wurde eine Risikoabschätzung erstellt. In der 
ersten Studie wurden vom Implantat losgelöste Ti-Partikel (0,5-5 µm) im Knochenmark 
festgestellt und in der zweiten Studie wurde die zelluläre Aufnahme von Ti-Partikel mit 
unterschiedlicher Größe bestimmt was schlussfolgern lässt auf die Toxizität und den 
Transport von Ti-Partikel im humanen Knochen und Knochenmark. 
4.2.1 Analyse von Ti und anderen Metallen im menschlichen Kieferknochen mit 
Dentalimplantaten  
4.2.1.1  ICP-OES   
Unter den analysierten Elementen zeigte nur Ti signifikant höhere Gehalte beim Vergleich 
der Testgruppe mit der Kontrollgruppe. Der höchste Gehalt in der Testgruppe war 37700 
µg/kg Knochengewicht. Die Proben wurden aus der Rechtsmedizin und der Anatomie der 
LMU München gewonnen. Wegen der ethischen Gesetzgebung ist es nicht möglich, 
detaillierte Informationen zu den Implantaten der Testgruppe zu geben, wie das “Alter” der 
Implantate, der Typ des Implantats, die Methode der Implantation, die 
Oberflächenbehandlung des Implantats und die schon vor der Implantation im Titankörper 
vorhandenen Verunreinigungen. Ti-Implantate können Ti-Verbindungen im menschlichen 
Knochen deponieren. Unter den 35 Knochenscheiben von sieben Knochenproben war in der 
Testgruppe der höchste Ti-Gehalt mit 37700 µg/kg Knochengewicht zu finden.  
4.2.1.2  LA-ICP-MS  
Die Verteilung von 13 Isotopen (47Ti, 27Al, 43Ca, 52Cr, 59Co, 63Cu, 57Fe, 39K, 55Mn, 60Ni, 51V, 
64Zn und 66Zn)  in den Knochenproben 4-7 mit Implantat wurde mittels LA-ICP-MS gemessen. 
In Knochenproben ohne Implantat wurden keine erhöhten 47Ti Gehalte gemessen. Erhöhte 
47Ti Intensitäten wurde bei den Proben 4-7 im Implantat naheliegenden Regionen (zwischen 
556-1587 µm entfernt von der Implantat Oberfläche) gemessen. Dies zeigt, dass Ti vom 
Implantat in den umgebenden Kieferknochen oder sogar in das Kieferknochenmark wandern 
kann. Die Intensität von 47Ti steigt an mit abnehmender Distanz zum Implantat und zeigt, 
dass die Verteilung von 47Ti im Kieferknochen von der Distanz zum Implantat abhängt. 47Ti 
befindet sich nicht nur im Implantat nahem humanen Kieferknochenmark, sondern auch in 
der das Implantat umgebenden kortikalen und trabekularen Knochenmatrix.  
4.2.1.3 Histologische Untersuchungen  
In der vorliegenden Studie zeigten SEM-Aufnahmen Ti-Partikel mit einer Größe von 0,5-5 µm 
im humanen Kieferknochenmark. Klinische Studien zeigten, dass Partikel aus Ti und Ti-
Legierungen in der Größe von 0,01 µm (10 nm) bis zu 50 µm im menschlichen Körper von 
Ti-basierten Implantaten und Prothesen freigesetzt werden können [19, 45] und Tierversuche 
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lieferten den Nachweis von Ti-Partikeln und –Überresten in der Größe zwischen 3 µm und 
250 µm im Implantat nahen Knochen oder Gewebe [7, 15]. Die von uns untersuchten Partikel 
lagen innerhalb dieses Größenbereichs. Vorhergehende Studien zeigten, dass Partikel <1 
µm von nicht phagozytierenden eukaryotischen Zellen per Endozytose aufgenommen 
können [46] und Partikel deren Durchmesser 0,75 µm überschritten von Makrophagen, 
Neutrophilen und Monozyten durch Phagozytose, oder durch Makropinozytose (>1 µm) von 
allen Zelltypen aufgenommen werden [47]. Deshalb ist der Transport von Ti-Partikel mit einer 
Größe von 0,5-5 µm ins Zellinnere möglich, so wie auch in der vorliegenden Studie im 
humanen Knochenmark beobachtet wurde.  
Knochenmarkfibrose und mehrkernige Riesenzellen nahe dem Implantat wurden in dieser 
Studie festgestellt. Ebenso zeigte eine vorhergehende post mortem Studie über von 
Implantaten freigesetzten Metallpartikel, Fibrosen in Lymphknotengewebe [22]. Weiterhin 
wurden mehrkernige Riesenzellen in periodontalen Rattengewebe beobachtet nach 
Implantierung von Hydroxyapatit [48]. Knochenmarkfibrose kann von Knochenmark-
verletzungen und Entzündungen verursacht werden [49]. Diese Auswirkungen wurden in 
Zusammenhang mit chirurgischen Traumata während des Einsetzens von Implantaten 
festgestellt [50]. Mehrkernige Riesenzellen können im prothesennahen humanen Gewebe von 
eingetragenen Partikeln aufnehmen und diese Zellen können phagozytierte Partikel enthalten 
[51]. Darum können die beobachteten Knochenmarkfibrosen und mehrkernige Riesenzellen in 
Zusammenhang mit den Zahnimplantaten stehen.  
4.2.2 Intrazelluläre Aufnahme und Toxizität von drei verschiedenen Ti  partikelarten 
In dieser Studie wurde das toxische Potential von Ti-NPs, Ti-MPs und NiTi-MPs in PDL-hTERT 
Zellen gemessen und in Hinblick auf ihre Partikelgröße und zellulare Aufnahmeeffizienz 
verglichen.  
4.2.2.1 Zytotoxizität: XTT-Versuch und Zelltod 
Es wurde bereits veröffentlicht, dass die Zytotoxizität von Nanopartikeln von der großen 
Oberfläche im Verhältnis zur Masse, beim Freisetzen toxischer Ionen und von ihrer Fähigkeit 
die Zellmembran zu passieren, hervorgerufen werden kann [38, 52]. In der vorliegenden Studie 
wurde der XTT-Test und der Trypanblau Farbausschlusstest benutzt um die Zytotoxizität von 
Ti-NPs, Ti-MPs und NiTi-MPs in PDL-hTERT Zellen zu messen. Die Ergebnisse des XTT-Tests 
ergaben, dass Ti-NPs eine höhere Toxizität verursachen als Ti-MPs, was auch durch den 
Trypanblau Farbausschlusstest bestätigt wurde.  
Frühere Studien zeigten, dass Ti-Partikel kleiner als 150 µm keine Zytotoxizität in 
menschlichen Fibroblasten generieren [53, 54], aber 10 µg/ml TiO2 Nanopartikel mit einer 
Größe von 30 nm können die Zellvitalität in Amnionepithelzellen um 40% reduzieren [54]. 
Unsere Ergebnisse ergaben, dass die EC50 von Ti-MPs (<44 µm) in PDL-hTERT Zellen über 
999 mg/ml lag, während die EC50 von Ti-NPs mit Größen zwischen 20 nm und 250 nm in der 
4 Synopsis/Zusammenfassung 
16 
 
Konzentration von 2,84 mg/ml war [55]. Unter Bezugnahme auf den höchsten im menschlichen 
Knochen gemessenen Ti-Gehalt (37700 µg/kg) wurde die folgende Berechnung einer groben 
Risikobewertung für ein “Worst Case Szenario” durchgeführt: Es wird angenommen, dass der 
Ti-Gehalt in 1 kg Knochen der Ti-Konzentration in einem Liter Flüssigkeit entspricht. Dies ergibt 
eine maximale Ti-Konzentration von 38 µg/ml. Es wird ferner angenommen, dass diese 
Konzentration nur Ti-NPs enthalte, so ergibt sich ein Gehalt von 38 µg/ml, der ca. 74 mal 
kleiner als der EC50-Wert von Ti-NPs ist [55].  
4.2.2.2 DNA-Schädigung  
Zur Bestimmung der von Ti-Partikel verursachten DNA-Schädigung wurde der Comet-Assay 
durchgeführt, welcher ergab, dass 14 µg/ml Ti-NPs in PDL-hTERT Zellen einen 1,5 fachen 
Anstieg der OTM-Werte im Vergleich zur Negativkontrolle bewirkten, während die ca. 500-
fache Konzentration (6666 µg/ml) an Ti-MPs nötig war, um das gleiche Ausmaß an DNA-
Schäden zu erzeugen, wie mit den Ti-NPs. Der Anstieg der OTM-Werte ist ein Indikator für 
DNA-Schäden [43, 44]; So stellen Ti-NPs ein 500-fach höheres DNA-Schädigungspotential dar, 
verglichen mit Ti-MPs. Gegenteilig wurde in vorigen Studien gefunden, dass Fe2O3- und TiO2- 
Nanopartikel signifikant (p<0,05) weniger DNA-Schäden verursachen (5% geringerer Schweif), 
verglichen mit den entsprechenden Makropartikel in der gleichen Konzentration [37]. Aber es 
wurde auch gefunden, dass Nanopartikel aus ZnO oder CuO mehr DNA-Schäden verursachten 
als ihre entsprechenden Makropartikel: ZnO-Nanopartikel verursachten eine signifikante 
Zunahme der DNA-Schäden in humanen Nasenschleimhaut-Zellen beginnend mit einer 
Konzentration von 10 µg/ml (p<0,05), im Vergleich zur Negativ-Kontrolle, während bei ZnO-
Makropartikel der gleichen Konzentration keine DNA-Schäden gesehen wurden [38]. CuO-
Nanopartikel (40 µg/cm2) induzierten nach vierstündiger Exposition in humanen A549-Zellen 
vier Mal mehr DNA-Schäden, im vergleich zur Kontrolle, die gleiche Konzentration an CuO-
Mikropartikel  verursachte nur 0,5 fachen mehr DNA- Schäden [37].   
4.2.2.3 Zelluläre Aufnahme 
Ti-NPs erreichten die höchste zelluläre Partikelaufnahmerate. Die aufgenommenen Partikel 
waren allerdings kleiner, verglichen mit Ti-MPs und NiTi-MPs, was indiziert, dass die Aufnahme 
von Ti-Partikel in PDL-hTERT Zellen größenabhängig ist. Dieses Ergebnis für Ti-NPs bestätigt 
frühere Studien. Diese Studien ergaben, dass nicht phagozytierende eukaryotische Zellen 
Partikel kleiner als 1 µm aufnehmen können [46] und dass die zelluläre Aufnahmerate von 
Nanopartikel von der Partikelgröße abhängig ist [41, 42, 56]: Nanopartikel erzielten höhere 
Aufnahmeraten als größere Partikel im Mikrometerbereich. In der vorliegenden Studie wurde, 
verglichen mit Ti-MPs und NiTi-MPs, für Ti-NPs sowohl die höchste zelluläre 
Partikelaufnahmerate, als auch die höchste Zytotoxizität gefunden. Analoge Resultate ergab 
eine frühere Studie, in welcher die Toxizität von Silizium-Titan Hohlkörper (SiTi)-Nanopartikel 
auf Makrophagen mit der Partikelaufnahmerate korrelierte. Der Vergleich verschiedener Si-
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Nanopartikel mit unterschiedlicher Größe und Oberflächenbeschichtung ergab in J774A.1 
Makrophagenzellen für den gleichen Partikeltyp, die kationischen SiTi-Nanopartikel (50 nm), 
sowohl höchste Partikelaufnahmeraten als auch die höchsten toxischen Effekte (z.B. 
Zytotoxizität) [39]. Unsere Ergebnisse zeigten, dass die zelluläre Aufnahme von Ti-Partikeln 
einher geht mit toxischen Effekten an den Zellen. Des Weiteren zeigen die Ergebnisse, dass 
nur Ti-NPs im Zellkern gefunden wurden und dass Ti-NPs mehr DNA-Schäden verursachten, 
verglichen mit Ti-MPs und NiTi-MPs. So kann das höhere DNA-schädigende Potential von 
Nanopartikel durch die Aufnahme der Nanopartikel in den Zellkern erklärt werden. 
Schlussfolgerungen: 
Der höchste Kieferknochen-Gehalt von Ti, der aus Dentalimplantaten freigesetzt wurde, war 
in dieser Studie 37700 µg/kg Knochengewicht, was mehr als 70-mal geringer ist, als die EC50 
von Ti-NPs in menschlichen PDL-hTERT Zellen. Ti-Partikel mit einer Größe zwischen 0,5 µm 
und 40 µm wurden nahe dem Implantat im humanen Kieferknochenmarkgewebe entdeckt, 
was im Knochenmark zur Bildung von vielkernigen Riesenzellen und Fibrosen führen kann.  
Durch die Besonderheit ihrer geringen Partikelgröße haben Ti-NPs eine höhere zelluläre 
Aufnahmerate und können stärkere toxische Effekte auslösen, verglichen mit den anderen 
Ti-Partikeln. Deshalb könnte die zelluläre Ti-Partikelaufnahme auch toxische Effekte in 
humanen Zellen auslösen. Berechnungen auf das “Ti-Worst Case Szenario” in der 
menschlichen physiologischen Situation ergeben, dass Ti-Implantate keine negativen 
Auswirkungen im klinischen Einsatz darstellen. Die Ergebnisse dieser Studie indizieren 
jedoch, dass Ti, freigesetzt aus menschlichen Ti-Implantaten, als nicht völlig inert anzusehen 
ist. 
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Objective. The aim of this study was to measure titanium (Ti) content in human jawbones
and  to show that Ti was released from dental implants inserted into these jawbones.
Methods. Seven samples from four  human subjects with dental implants were  analysed as
test  group and six bone samples of similar topographical regions from six human sub-
jects without implants served as control. The contents of various elements in human
jawbones were detected by  inductively coupled plasma optical emission spectrometry. The
distributions of various isotopes in human mandibular bone were measured with laser
ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS). Histological analy-
ses  of undecalcified, Giemsa-Eosin stained mandible sections were  performed by light
microscopy and particles were identified in human bone marrow by scanning electron
microscope-energy dispersive X-ray analysis.
Results.  In  test group only Ti content was significantly higher compared to control group. The
mean contents of Ti were 1940 g/kg in test group and 634 g/kg in control group. The highest
Ti  content detected in human mandibular bone was 37,700 g/kg-bone weight. In samples
4–7  (human subjects II–IV), increased Ti intensity was also detected by LA-ICP-MS in human
mandibular tissues at a  distance of 556–1587 m  from implants, and the  intensity increased
with decreasing distance from implants. Particles with sizes of 0.5–40 m were found in
human jawbone marrow tissues at distances of 60–700 m  from implants in samples 4–7.
∗ Corresponding author at: Department of Operative/Restorative Dentistry, Periodontology and Pedodontics, LMU Munich, Goethestr. 70,
80336  Munich, Germany. Tel.: +49 89 2180 73842; fax: +49 89 2180  73841.
E-mail  address: christof.hoegg@lrz.uni-muenchen.de (C.  Högg).
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0109-5641/© 2016 The Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
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Significance. Ti released from dental implants can be detected in human mandibular bone
and  bone marrow tissues, and the  distribution of Ti in human bone was related to the
distance to the implant.
©  2016 The Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
1.  Introduction
In the last 50 years titanium (Ti) and its alloys have been
widely used for dental and medical applications [1,2].  Clini-
cally, pure Ti (Ti >99%) and the alloy Ti-6Al-4V are mainly used
for endosseous implants [2]. Ti alloys with other metals (e.g.
nickel (Ni), chromium (Cr), iron (Fe), and molybdenum (Mo))
are applied for implant devices such as bone plates or  screws
[2,3]. Ti is the  main component in those implants/implant
devices so that a stable TiO2 layer [4,5] on the surface can
provide Ti  based implants/implant devices with a  high bio-
compatibility and resistance to  corrosion [6–9].
Although Ti based implants have been considered to be
biological inert, it has been found that implants in the body
can undergo corrosion and release particulate debris over
time [10,11].  It has been reported that the metallic debris
from Ti based implants might exist in  several forms includ-
ing particles (micrometer to nanometre size), colloidal and
ionic forms (e.g. specific/unspecific protein binding) [12,13],
organic storage forms (e.g. hemosiderin, as an iron-storage
complex), inorganic metal oxides and salts [12].  According
to a previous study [14], the degradation of implants in the
human body is primarily induced by wear and corrosion:
wear is the mechanical/physical form of implant degrada-
tion which produces particles; while corrosion refers to the
chemical/electrochemical form of degradation that mainly
produces soluble metal ions [14].  Ti particles released from
implants have been found in the regenerated bone and peri-
implant tissues in  animals [7,15].  It has  been shown that
also Ti ions can be released from embedded implants in
animals [16,17]. Ti particles/ions are able to enter the circu-
lation of blood and lymph  [12,18,19]. Ti particles detached
from hip, knee and mandible implants have been detected
in organs such as liver, spleen, lung and lymph  nodes [5,19].
Increased levels of elementary Ti have also been detected
in the blood of patients with poorly functioning implants
[12].
Increased concentrations of metals (e.g. Ti,  Cr, Co and Al)
derived from implants in body fluids might induce acute or
chronic toxicological effects [12]. The long-term effects of Ti
derived from implants are still not fully understood, but asso-
ciated hypersensitivity and allergic reactions in patients have
been reported [20,21].  In a  clinical study, 0.6% of 1500 patients
were found to exhibit Ti allergic reactions [20].  Additionally,
it has been found that detached metal debris from implants
might cause marrow fibrosis, necrosis and granulomatosis
[22–24].
The aim of our study was  to measure the release of Ti
and other metallic elements from dental implants through
detailed post-mortem studies of human subjects with den-
tal implants. In the present study, Ti released from implants
inserted into human jawbones was identified and quantified,
and the spatial distribution of Ti in human jawbones near
implants was also investigated.
2.  Materials  and  methods
2.1.  Materials
The test group contained 7 samples from four human subjects
with dental implants (Table 1).  The control group contained
6  bone samples from similar topographical regions from six
human subjects without dental implants.
The bodies were individually donated for medical research.
Subjects I–III in the test group and all six of the subjects
from the control group were obtained during the dissection
course of the anatomical institute of the Ludwig-Maximilian-
University Munich. Bone implant sample from subject IV
was supplied by the institute of forensic medicine of the
Ludwig-Maximilian-University Munich. Subjects I–III carried
two implants (one on each side of the mandible) replacing the
mandibular canine teeth (FDI System: 33, 43). Subject IV car-
ried two implants that replaced the left first and second molars
in the mandible (FDI System: 36  and 37). All the  lower jaw-
bones in  the test group contained no additional natural teeth.
Four out of the six  control subjects were toothless as well. The
other two control subjects were partially edentulous. The aver-
age age of the subjects in the test group (excluding subject IV)
and control group were 88 and 85 years, respectively.
For subjects I–III,  each of the  two implants with the adja-
cent jawbone was taken as  a single sample; for subjects IV,
two implants with adjacent jawbone on each side were taken
as a  single sample. Therefore, there were seven implant sam-
ples in our experiment (Table 1). Implants used in samples
5–6  were produced by Astra Tech implant system (Mannheim,
Germany), and the implants used for sample 4 and sample
7  were produced by Straumann AG (Basel, Switzerland). The
manufacturers of the implants of samples 1–3 were unknown.
Due to ethical consideration, it is not possible to get  more
information about the implants, such as  the “age” of the
implants (for how many  years it has been loaded), the  type
of the implants and the surface treatment on the implants.
Ti dental implants have no identification number to provide
detail information (e.g. for age determination).
2.2.  Sample  analysis  by  inductively  coupled  plasma
optical  emission  spectrometry  (ICP-OES)
2.2.1.  Sample  preparation
All 7 samples of test group and all 6  samples of control
group had been fixed in 4% buffered formalin (Merck, Darm-
stadt, Germany). The soft tissue was cautiously removed
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Table 1 – Summary information for the test group.
Subject number Age Gender Implants Sample number
No. I 98 Female 2 pieces, on  the positions of  both
of the  both mandibular canine
teeth (FDI System: 33, 43)
No. 1: right mandible
segment
No.  2: left mandible
segment
No. II 83 Female 2 pieces, on  the positions of  both
of the  mandibular canine teeth
(FDI System: 33, 43)
No. 3: left mandible
segment
No. 4: right mandible
segment
No. III 84 Male 2 pieces, on  the positions of  both
of the  mandibular canine teeth
(FDI System: 33, 43)
No. 5: right mandible
segment
No.  6: left mandible
segment
No. IV Unknown Female 2 pieces, on  the positions of  the
left first and second molars in the
lower jaw (FDI System: 36  and 37)
No. 7: left Mandible segment
with Feather® disposable stainless steel scalpels and then
immersed in 100% methanol (Carl Roth, Karlsruhe, Germany).
2.2.1.1.  Test  group.  Jawbone slices in  the  sagittal plane were
prepared from samples 1–7 by cutting with a diamond band
saw (cut-grinder macro, patho-service GmbH, Oststeinbek,
Germany). The samples were cut at intervals of 1 mm in
a direction moving toward the implants, and cutting was
stopped immediately adjacent to the implant (Fig. 1). From
each sample, at least 5 jawbone slices with an approximate
thickness of 500 m were obtained. For analysis the 5 jawbone
slices closest to the implant were used.
Each jawbone slice was  further divided into 4 quadrants
(A–D) (Fig. 1). Each quadrant was  weighed and dissolved in 1 ml
sub-boiled distilled nitric acid at 170 ◦C for 12 h. The solution
was subsequently diluted (1:5) in Milli-Q Water. The contents
of the elements Ti, Al, Cd, Cr, Co, Cu, Fe, Mn, Mo, Ni and V
in each quadrant were analysed by ICP-OES (Optima 7300 DV,
Perkin Elmer, Rodgau-Jügesheim, Germany). The remaining
specimens containing the implant and adjacent bone were
reserved for further analysis (Sections 2.3 and 2.4).
2.2.1.2.  Control  group.  Control samples were taken from
mandibular regions topographically comparable to  those bear-
ing the implants. Again 5 adjacent jawbone slices were cut and
each of the slices was divided into 4 quadrants. For analysis
by ICP-OES, same procedure as  samples 1–7 was  performed.
2.2.2.  Analytical  procedure
An  ICP-OES, Optima 7300 DV system (Perkin Elmer, Rodgau-
Jügesheim,Germany) was used for element determination.
Sample introduction was carried out using a  peristaltic pump
connected to  a Seaspray nebulizer with a cyclon spray cham-
ber. The measured spectral element lines were (in nm): Al:
167.078, Cd: 214.438, Cr: 267.716, Co: 228.616, Cu:  324.754, Fe:
259.941, Mn: 257.611, Mo: 202.030, Ni: 231.604, V: 292.464, Ti:
334.941.
The RF power was  set to  1400 W;  the plasma gas was 13 L
Ar/min, whereas the nebulizer gas was approximately 0.6 L
Ar/min after daily optimization.
Routinely each ten measurements, three blank determina-
tions and a control determination of a  certified standard for all
mentioned elements were performed. Calculation of results
was  carried out on a computerized lab-data management sys-
tem, relating the sample measurements to calibration curves,
blank determinations, control standards and the weight of the
digested sample.
The volumes of sample digests were sufficient for duplicate
measurements (n = 2).
Fig. 1 – Scheme (X-ray image) of the cutting procedure for samples 1–7:  at least five bone slices were  obtained from each
sample; each slice was divided into 4 quadrants (A, B, C and D). The red lines represent the cuts, and the distance between
two cuts is 1 mm,  the numbers represent slice numbers, number 1 represents the slice closest to implant. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web  version of this article.)
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2.2.3.  Calculations  and  statistics
For a total jaw bone slice the content (g/kg) of each inves-
tigated element was calculated by dividing the summed
concentrations of the 4 quadrants with their summed masses.
The results are presented as mean ±  standard error of the
mean (SEM). Independent two-sample t-test and a  one-way
ANOVA analysis followed by post hoc Bonferroni adjustment
were performed for statistical analysis. Differences were con-
sidered statistically significant only when the p-value was less
than 0.05 (p < 0.05) [25].
2.3.  Content  distribution  measured  by  Laser
Ablation-Inductively  Coupled  Plasma-Mass  Spectrometry
(LA-ICP-MS)
2.3.1.  Sample  preparation
The remaining parts of samples 4–7 (the bone surrounding
the implants) and bone samples from the control group were
dehydrated in ascending ethanol fractions (70%, 80%, 90% and
100%), defatted in xylene (Merck, Darmstadt, Germany), and
embedded in methylmethacrylate (Fluka, Switzerland). Sam-
ples 4–7 were analysed because in  these samples significantly
higher Ti contents (compared to controls) were detected with
ICP-OES measurement in  Section 2.2.
Details of the embedding and cutting process can be found
in a previous study [26]. The polymerized methacrylate blocks
were cut at a thickness of approximately 300 m parallel to
the long axis of the implants in the mesio-distal plane using
a Leica SP 1600 saw-microtome (Leica, Wetzlar, Germany).
The sections were used for spectroscopy and for histological
analysis.
The distribution of the isotopes 47Ti, 27Al, 43Ca, 52Cr, 59Co,
63Cu, 57Fe, 39K, 55Mn, 60Ni, 51V, 64Zn  and 66Zn in each sec-
tion were analysed by Laser Ablation-Inductively Coupled
Plasma-Mass Spectrometry (LA-ICP-MS) – NWR-213® (New
Wave Research Co. Ltd.) coupled to a NexION® 300 ICP-MS
(PerkinElmer).
2.3.2.  Analytical  procedure
The laser ablations started from the bone region at a dis-
tance of 5 mm  from the implant and ended in the implant
region. In this manner, sample-specific backgrounds could
be measured by moving from low to high contents [27],  and
memory  effects were avoided. Two to three parallel ablation
lines with each time 6 measurements into the deep (10 m
depth ablation per measurement) were performed for each
jawbone slice. The average value of 2–6  measurements was
calculated for each line (the first measurement was discarded
in order to eliminate possible contamination on the surface of
the bone sections which could have occurred during the cut-
ting process). Instrument settings and parameters are shown
in Table 2.
After the laser ablations, contact radiographs (Faxitron X-
ray Corporation, Lincolnshire, IL, USA) for each section were
taken on Agfa Strukturix X-ray sensitive film (Agfa-Gevaert,
Mortsel, Belgium). The laser lines were clearly visible on
the X-ray film and were photographed with an  Axiophot
microscope (Zeiss, Goettingen, Germany), equipped with Zeiss
Plan-Neofluar objectives (5×  and 10×) in  transmitted light
mode.
Table 2 – Instrument settings for LA-ICP-MS.
Laser Energy: 0.930 mJ
Power: 100%
Pulse repetition rate: 10 Hz
Scan speed: 35 m/s
Spot size:  50  m
Ablation pattern: line
Depth: approx. 10 m
ICP Plasma power: 1200  W
Transport gas: 1.2 L/min Ar
Auxiliary gas: 0.8 L/min  Ar
Cool gas: 17  L/min Ar
MS Registered isotopes: 47Ti, 27Al, 43Ca, 52Cr, 59Co,
63Cu, 57Fe, 39K, 55Mn, 60Ni, 51V, 64Zn  and 66Zn
Dwell time/isotope: 25  ms
2.4.  Histological  analysis
2.4.1.  Sample  preparation
From each of the samples 4–7, one of the sections (cutting
procedure described in Section 2.3.1) was  glued (Cyanolit
201, Panacol LTD., Zürich, Switzerland) on opaque plastic
slides, ground thinner, polished (EXAKT® 400CS grinding sys-
tem, EXAKT Vertriebs GmbH, Norderstedt, Germany) and
stained with Giemsa-Eosin stain (Sigma Aldrich, Steinheim,
Germany).
The same procedure was applied for the  control samples.
2.4.2.  Light  microscopy  observation  and  scanning  electron
microscope-energy  dispersive  X-ray  (SEM-EDX)
measurements
The stained sections were examined with an Axiophot micro-
scope (Zeiss, Goettingen, Germany) that was equipped with
Zeiss Plan-Neofluar objectives (5×  and 10×) in transmitted
light mode. Images were recorded with an  Axciocam HRc dig-
ital camera (Zeiss, Goettingen, Germany).
The sections that contained visible dark particles were
coated with gold and investigated with a SEM (EVD MA  15)
equipped with secondary electron (SE) and back-scattered
electron (BSE) detectors. The energy dispersive X-ray (EDX)
analyses were performed using an  Oxford INCA Penta Fetx 3.
The samples of the  control group were also histologically
investigated, coated with gold and analysed by SEM-EDX.
3.  Results
3.1.  Sample  analysis  by  ICP-OES
Among all the investigated elements (Ti, Al, Cd, Cr, Co, Cu,
Fe, Mn,  Mo, Ni and V), only the  element Ti in the test group
(samples 1–7) showed significantly higher content compared
to the control group (p < 0.05).
Ti contents of each total jawbone slice from samples 1–7
and control group are shown in Fig. 2.  The highest Ti con-
tent (13,205 g/kg-bone weight) of all slices was detected in
sample 6. The average Ti content across all 35 bone slices
(n = 35) of samples 1–7 (1940 ± 469 g/kg-bone weight) was  sig-
nificantly higher compared to the average content across the
30 bone slices (n = 30) from the control group (634 ± 58 g/kg-
bone weight).
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Fig. 2 – Ti contents in the total bone slices from implant
samples 1–7 and all control samples. The X-axis represents
the number of bone slices; the interval between each two
numbers is 1 mm.  The Y-axis represents the contents of Ti
measured in each total bone slice.
Ti contents of the total jawbone slices with approximately
the same distance from the implant (distance identified by
same slice numbers) of all 7 samples are shown in  Fig. 3
(mean ± SEM). There were no significant differences in Ti con-
tent averages between slices obtained at different distances
from the implants (p > 0.05).
The average Ti contents for each of the four quadrants
(samples 1–7) are shown in Fig. 4. Quadrant B in  slice 2  of
sample 6 showed the  highest Ti content (37,700 g/kg-bone
weight) compared to all the other single quadrants (Fig. 5).
The sum of the average Ti contents in the  upper half of the
bone slice – quadrants A + B (7064 ± 1932 g/kg-bone weight)
– is significantly higher compared to the sum of the aver-
age Ti contents in the  lower half of bone slice – quadrants
C +  D (1327 ±  256 g/kg-bone weight) (Fig. 6). Within the  control
group there were no significant differences of the Ti contents
calculated for all combinations of quadrants or slices.
Fig. 3 – Ti contents in each total bone slice in  various
distances to implants, the x-axis represents the number of
bone slices, the interval between each two  numbers is
1 mm,  and error bars represent the SEMs.
Fig. 4 – The average Ti contents of 4 quadrants of all bone
slices from 7 samples in test group (mean ± SEM), *p < 0.05.
3.2.  Distribution  of  isotopes  measured  by  LA-ICP-MS
The isotopes 47Ti, 27Al, 43Ca, 52Cr, 59Co, 63Cu, 57Fe, 39K, 55Mn,
60Ni, 51V, 64Zn and 66Zn in  the  bone slices with longitudi-
nal cuts through the implants of samples 4–7  (which showed
higher Ti content compared to control group measured by
ICP-OES) were detected by LA-ICP-MS. Qualitative results are
shown in Table 3. 47Ti was the  only isotope of all investigated
isotopes that could be detected in implant and human jaw-
bone/jawbone marrow tissue of samples 4–7  (with implant)
but not in the control samples without implants.
For samples 4–7  along the ablation lines different intensi-
ties of 47Ti were detected. In sample 4 the distribution of 47Ti
along one ablation line showed that the average 47Ti intensity
in a bone region within about 966 m from the implant is 14
times higher compared to average value of bone at a distance
>966 m from the  implant. Samples 5–7  showed comparable
Fig. 5 – Ti contents in 4 quadrants of all slices in sample 6,
slice numbers 1–5 represent all slices analyzed in sample 6,
number 1 represents the slice closest to implant.
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Table 3 – The distribution of the isotopes measured by LA-ICP-MS in the detected bone slices.
Sample numbers Isotopes in implants (>99%) Isotopes in bone/bone marrow tissues
4 47Ti  (94%), 52Cr (4%), 55Mn  (0.55%), 56Fe (0.52%), 60Ni  (0.42%) 27Al, 39K, 43Ca, 47Ti, 53Cr, 64Zn, 66Zn
5 47Ti (94.8%), 27Al (4.5%), 51V (0.23%), 52Cr (0.14%) 27Al, 39K, 43Ca, 47Ti, 53Cr, 64Zn, 66Zn
6 47Ti  (98.2%), 27Al (0.68%), 52Cr (0.16%) 27Al, 39K, 43Ca, 47Ti, 53Cr, 64Zn, 66Zn
7 47Ti (93.7%), 27Al (5.3%), 52Cr (0.25%), 60Ni (0.21%) 27Al, 39K, 43Ca, 47Ti, 64Zn, 66Zn
Control – 27Al, 39K, 43Ca, 53Cr, 64Zn, 66Zn
Fig. 6 – The average Ti contents in the upper part (A  + B) and
lower part (C + D) of each slice in the test group. The error
bar represents the SEM, *p < 0.05.
results for 47Ti: increased intensities of 47Ti were also detected
at distances nearer than 556–1587 m to the implant surfaces.
Fig. 7 shows the X-ray image  of the ablation line in  the bone
slice of sample 4 combined with LA-ICP-MS results (distribu-
tions of 43Ca and 47Ti).
3.3.  Histological  analyses
The histological analysis was performed for samples 4–7 and
the control group. Continuous bone contact with the  implant
Fig. 7 – X-ray image of one laser ablation line (the part near
implant) in sample 4 combined with LA-ICP-MS result
(implant screw = white, bone = gray, bone marrow
tissues = black).
surface was observed for sample 4 and sample 5 by light
microscopy, while observation of samples 6 and 7 showed only
bone implant contact at isolated spots. Observation of sam-
ples 4–7 by light microscopy revealed black dots between the
cells of the bone marrow tissue, which were identified as Ti
particles by SEM-EDX analysis. Primary location of Ti parti-
cles was in  the  bone marrow tissue at a distance of 60–700 m
from the implant, with particle sizes <40 m (Fig. 8a and b).
Fig. 8c shows multinucleated cells in the bone marrow tis-
sues near implant. Local avital bone regions were identified
in Fig. 8d by the absence of cell nuclei throughout the lacu-
nae of the mineralized tissue. Fig. 8e reveals traces of marrow
fibrosis, an  indication of previous inflammatory reactions. No
Ti particles, no signs of fibrosis, no avital bone tissue and no
multinucleated cells were found in  the  control group (Fig. 8f).
Results of Ti particle identification by SEM-EDX are shown
in Fig. 9a–c. Ti particle size measurement revealed sizes from
0.5 to 5 m (detection limitation of SEM for magnification fac-
tor used in present method is  0.5 m).
4.  Discussion
In this study, Ti released from dental Ti implants in human
jawbones was measured and identified with ICP-OES, SEM-
EDX and LA-ICP-MS. It is very rare to get human jawbones
with dental implants. Within  4 years only 7 samples with jaw
Ti-implants have been obtained from four human individuals
from the anatomical institute and forensic medicine institute
of the Ludwig-Maximilians-University Munich. This is the first
study investigating Ti release from dental implants in human
jawbone.
Due to ethical considerations and privacy protection it is
not possible to get more  information about the implants, such
as  the  “age” of the implants (for how many years it has been
loaded), the type of the implants, the method of surgeon and
surface treatment of the implants and impurities present in
the implant before insertion. Furthermore, the research in  this
study is focused on the Ti release from Ti implants in  human
jawbones compared to  controls without Ti implants. There-
fore, influences of factors like “age” or “type of implants”, etc.
play no role for this research. The individuals in  the test and
the control groups examined in the present study were highly
comparable with respect to age and gender distribution.
4.1.  ICP-OES
Among the analysed elements Ti, Al, Cd, Cr, Co, Cu, Fe, Mn,
Mo, Ni and V, only Ti showed significantly higher contents in
the test group compared to the control group.
Ti is commonly used for dental implants [6], and it has
already been found that Ti particles can be released into the
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Fig. 8 – The histological images of bone slices with/without implants. Slices (300 m thick) were  glued on opaque plastic
slides, ground thinner, polished and stained with Giemsa-Eosin. (a) Bone slice image taken in the combination of
transmitted light mode and reflected light mode, a coating layer (marked in rectangle) at  the implant surface could be
observed with oblique reflected light, particles are  visible in bone marrow tissues. The coated implant has a good contact
with bone. (b) Particles could be found in bone marrow tissues containing fat cells, and are further identified by  SEM-EDX
(shown in Fig. 9). The implant has a good contact with bone. (c) Bone slice with multinucleated cell (cell with more  than one
nucleus) in the bone marrow tissues near the implant. (d) Bone slice with avital bone marrow tissues (identified by the
absence of nuclei in the osteocyte lacunae) near the implant. A coating layer (marked with a rectangle) could also be
observed. (e) Bone slice with fibrosis in  the bone marrow tissues near the implant. (f) Bone slice without implant (control).
Fat cell = white, nucleus = blue, particle = black, bone marrow tissues (consist of cells) = white, bone = pink. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web  version of this article.)
bone tissues from implants [2,14,15].  However, there are less
data about the absolute and relative Ti content in human bone
surrounding dental implants.
A previous study showed that maximal 4000 g/kg-bone
weight of Ti in  rat  tibia bone tissues with Ti implant could
be detected by ICP-MS after 10 weeks implantation [28].  In
the present study, the average content of Ti in  the  test group
measured by ICP-OES (1940 g/kg-bone weight) was  3 times
higher compared to the control group. The highest Ti content
of all bone quadrants was 37,700 g/kg-bone weight. Accord-
ing to previous studies [29,30], Ti particles (<150 m)  exhibited
no cytotoxicity in human fibroblasts [29,30],  but 10 g/ml of
TiO2 Nanoparticles (NPs) with a  size of 30  nm induced 40%
reductions in the cell viabilities of human amnion epithelial
cells [30]. Additionally, previous study of our group showed
that the EC50 of  Ti microparticles (<44 m)  in PDL-hTERT cells
was above 999 mg/ml, while the EC50 of Ti nanoparticles (NPs)
(20–250 nm)  was 2.84 mg/ml  [31].  Regarding the highest Ti con-
tent (37,700 g/kg), the following calculation for rough risk
assessment can be  given: assuming that Ti in  1 kg bone corre-
sponds to Ti in  1 L fluid, a  maximal Ti concentration of 38 g/ml
can be calculated. This value is 3.8 times higher compared to
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Fig. 9 – SEM image and EDX analysis of the section with particles in Fig. 8(b). (a) Backscattered (BSD) SEM image: Ti
implant =  white gray, particles = white gray, bone marrow tissues = dark gray, bone = gray. (b) Magnification of the region with
particles shown in (a) by  SEM. Particles (white gray) could be visualized inside the bone marrow tissues (gray). (c) EDX
analysis of the region with particles in (a). On the left is the SEM image of the detected region, in the middle is the intensity
of Ca in detected region (bone = gray, bone marrow tissue = black), and on the right is the intensity of Ti  in detected region (Ti
particles = white gray). The particles in the bone marrow tissues in Fig. 8(b) are identified as Ti particles.
reported cytotoxic concentration (10 g/ml) of TiO2 NPs [30]
and 74 times lower compared to the EC50 (2.84 mg/ml) of Ti
NPs [31].
ICP-OES results revealed no distance-dependence of the
47Ti distributions in the  total jawbone slices (slice 1–5) of each
sample, but the 47Ti  contents in the  upper quadrants A  + B of
the bone slices in test group were 5-time higher compared
to the lower quadrants C + D. The bone quadrants A + B are
anatomically regarded as  the alveolar bone, which is known
to have a remodeling behavior reacting very sensitive to  the
transmitted load. Previous studies also reported that the  max-
imum stress (e.g. masticatory forces) is distributed around the
implant neck which is  surrounded by alveolar bone [32,33].
Obviously, this might explain the higher 47Ti content in the
upper quadrants in  the current study. Moreover, the main part
of the implant is anchored in  the  upper part of the jawbone,
so the upper quadrants A + B of the bone slices are closer to
the implant compared to the lower quadrants C  + D, and this
shorter distance to implant may result in the higher 47Ti con-
tent as well. Additionally, the  upper quadrants might receive a
considerable particle load during the  insertion of the implant,
which could also lead to higher 47Ti  content in the upper quad-
rants.
4.2.  LA-ICP-MS
Due to its flexible spatial analysis capability and high sen-
sitivity, LA-ICP-MS is  applied to measure elements, such
as Ca, Mg  and Sr in bones [27,34].  Moreover, this tech-
nique is able to detect unique elemental distributions in
micro-spatial areas of dental tissues [35]. In the  present
study, LA-ICP-MS was used to analyse the region immediately
adjacent to the implant because bone slice samples in  this
region cannot be obtained by the cutting method used for
ICP-OES.
The distributions of 13 isotopes 47Ti, 27Al, 43Ca, 52Cr, 59Co,
63Cu, 57Fe, 39K, 55Mn, 60Ni, 51V, 64Zn  and 66Zn in  bone sam-
ples 4–7 with implants were measured by LA-ICP-MS. In bone
samples without implant no increased 47Ti was detected.
Increased intensity of 47Ti for samples 4–7 was detected in
the bone region adjacent to the implant (about 556–1587 m
away from the  implant surface). In a  previous study, Ti parti-
cles from the implant were found in  the peri-implant sheep
tissue at a  distance >200 m from the implant [15]. Obviously,
Ti can migrate from the implant into the surrounding human
jawbone or jawbone marrow tissues. In addition, the intensity
of 47Ti increased with decreasing distance from the implants,
which suggests that the distribution of 47Ti in  the jawbone
depends on the distance from the  implant. This finding is con-
sistent with the  ICP-OES results showing that Ti content in
upper quadrants A  + B (closer to the implant) is significantly
higher compared to the lower quadrants C + D. The lack of
observations of distance-dependence across the  total bone
slices by ICP-OES might be attributable to the cutting method
not being able to obtain jawbone slices that were sufficiently
close to the implant.
43Ca can be taken as  an  indicator of bone [27]. In this
study, 43Ca distribution along the ablation line in the  bone
slices is shown. Interestingly, 47Ti is present not only in  the
peri-implant human jawbone marrow tissues but also in the
cortical or trabecular bone matrix adjacent to  the implant.
This is  in agreement with previously reported results showing
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that Ti particles are found not only in peri-implant animal
tissues but also in  the bone close to the implants [7,15].
4.3.  Histological  analyses
In the present study, the light microscopy and SEM-EDX results
show that Ti particles (0.5–40 m) are present in  human jaw-
bone marrow tissues at a  distance of 60–700 m from the
implant. Nearly identical results have been shown by the fol-
lowing studies: Ti particles (from the implant surface) were
able to be found in  the peri-implant sheep tissue at a dis-
tance >200 m from the implant [15];  Ti particles could not
only be observed in peri-implant tissues but also in newly
formed bone [7,15]. It was suggested that those Ti particles
might be detached during the insertion of the implant [7,36]
or released after insertion [14].
In the current study, SEM results showed Ti particles with
a size of 0.5–5 m in human jawbone marrow tissues. Previ-
ous studies reported that particles <1 m could be taken up
by non-phagocytic eukaryotic cells via endocytosis [37] and
particles with diameters exceeding 0.75 m can be taken up
by macrophages, neutrophils and monocytes via phagocyto-
sis or through macropinocytosis (>1 m)  by all cell types [38].
Therefore, transportation of Ti particles with size of 0.5–5 m
that were observed in  human bone marrow tissues of present
study into cells is possible. It should also be pointed out that
a particle smaller than approximately 1 m can no longer be
seen by transmitted light microscopy.
In this study, bone marrow fibrosis, avital bone tissues
and multinucleated cells were observed near the implant.
Similarly, a previous post-mortem study about metal particles
released from implants showed bone marrow fibrosis in
lymph-node tissue [22].  Furthermore, multinucleated cells
have been observed after hydroxyapatite implantation in
rat periodontal tissues [39].  Bone marrow fibrosis might be
induced by marrow injury and inflammation [40].  These
effects are reported to be associated with surgical trauma
during insertion of implants [41].  Multinucleated giant cells
can be elicited by wear particles in periprosthetic tissues
in human specimens and these cells might contain phago-
cytized wear particles [42]. These findings cited above are
in accordance with the  histological observations made in
undecalcified, resin embedded human bone and implant
sections in the  present study.
5.  Conclusion
Ti can be released into human jawbone and jawbone marrow
tissues from dental implants. Compared to all other investi-
gated isotopes only 47Ti was observed in  both the implants and
human bone/bone marrow tissues near the implant but not in
the control samples. The intensity of 47Ti in human jawbone
increased with decreasing distance to implant. Ti particles in
size between 0.5  m and 40 m were observed in  the jawbone
marrow tissues near the implant, which might induce fibro-
sis and multinucleated cells. Based on our study with a small
sample size we suggest that Ti dental implants might have no
adverse clinical effects.
Acknowledgements
This study was  financially supported by the China Scholarship
Council (CSC, 201206220099). We  would like to thank Mr.  Peter
Grill and Mr.  Stefan Schulz for the technical support.
r  e  f  e  r  e n c e  s
[1]  Lautenschlager EP, Monaghan P. Titanium and titanium
alloys as dental materials. Int Dent J 1993;43:245–53.
[2]  Elias C, Lima J, Valiev R, Meyers M. Biomedical applications
of titanium and its alloys. JOM 2008;60:46–9.
[3]  McCracken M. Dental implant materials: commercially pure
titanium and titanium alloys. J Prosthodont 1999;8:40–3.
[4]  Kasemo B. Biocompatibility of titanium implants: surface
science aspects. J  Prosthet Dent 1983;49:832–7.
[5]  Schliephake H, Reiss G, Urban R, Neukam FW, Guckel S.
Metal release from titanium fixtures during placement in
the  mandible: an  experimental study. Int J Oral Maxillofac
Implants 1993;8:502–11.
[6]  Okabe T, Hero H. The use of titanium in dentistry. Cells
Mater (USA) 1995;5:211–30.
[7]  Franchi M, Bacchelli B, Martini D, Pasquale VD,  Orsini E,
Ottani V, et al. Early detachment of titanium particles from
various different surfaces of endosseous dental implants.
Biomaterials 2004;25:2239–46.
[8]  Adya N, Alam M, Ravindranath T, Mubeen A, Saluja B.
Corrosion in titanium dental implants: literature review. J
Indian  Prosthodont Soc 2005;5:127.
[9]  Velasco-Ortega E, Jos A,  Cameán AM,  Pato-Mourelo J,
Segura-Egea JJ. In vitro evaluation of cytotoxicity and
genotoxicity of a commercial titanium alloy for dental
implantology. Mutat Res/Genet Toxicol Environ Mutagen
2010;702:17–23.
[10] Meachim G, Williams D. Changes in nonosseous tissue
adjacent to titanium implants. J  Biomed Mater Res
1973;7:555–72.
[11] Galante JO, Lemons J, Spector M, Wilson Jr PD, Wright TM.
The biologic effects of implant materials. J Orthop Res
1991;9:760–75.
[12] Hallab NJ, Mikecz K,  Vermes C,  Skipor A, Jacobs JJ.
Orthopaedic implant related metal toxicity in terms of
human lymphocyte reactivity to metal-protein complexes
produced from cobalt-base and titanium-base implant alloy
degradation. Mol Cell Biochem 2001;222:127–36.
[13] Hallab NJ, Jacobs JJ, Skipor A, Black J, Mikecz K, Galante JO.
Systemic metal-protein binding associated with total joint
replacement arthroplasty. J Biomed Mater Res
2000;49:353–61.
[14] Jacobs JJ, Gilbert JL, Urban RM. Current concepts review –
corrosion of metal orthopaedic implants. J Bone Jt Surg
1998;80:268–82.
[15] Martini D, Fini M, Franchi M, Pasquale VD, Bacchelli B,
Gamberini M, et al. Detachment of titanium and
fluorohydroxyapatite particles in unloaded endosseous
implants. Biomaterials 2003;24:1309–16.
[16] Edwin SH. Characteristics of trace ions released from
embedded metal implants in the rabbit; 1962.
[17] Ducheyne P, Willems G, Martens M, Helsen J. In vivo
metal-ion release from porous titanium-fiber material. J
Biomed Mater Res 1984;18:293–308.
[18] Brien WW,  Salvati EA, Betts F, Bullough P, Wright T, Rimnac
C, et al. Metal levels in cemented total hip arthroplasty. A
comparison of well-fixed and loose implants. Clin Orthop
Relat Res 1992:66–74.
d e  n t a l m a  t e r  i  a l s  3 2  ( 2 0  1 6 )  1042–1051 1051
[19] Urban RM, Jacobs JJ, Tomlinson MJ,  Gavrilovic J, Black J,
Peoc’h M. Dissemination of wear particles to the liver,
spleen, and abdominal lymph nodes of patients with hip or
knee replacement. J Bone Jt Surg Am 2000;82:457–76.
[20] Sicilia A, Cuesta S, Coma G, Arregui I,  Guisasola C, Ruiz E,
et  al. Titanium allergy in dental implant patients: a  clinical
study on 1500  consecutive patients. Clin Oral Implants Res
2008;19:823–35.
[21] Lalor PA, Revell PA,  Gray AB, Wright S, Railton GT, Freeman
MA.  Sensitivity to titanium. A cause of implant failure? J
Bone Jt Surg Br 1991;73:25–8.
[22] Case CP, Langkamer VG, James C, Palmer MR, Kemp AJ, Heap
PF, et al. Widespread dissemination of metal debris from
implants. J Bone Jt Surg Br 1994;76:701–12.
[23] Amstutz HC, Campbell P, Kossovsky N, Clarke IC.
Mechanism and clinical significance of wear debris-induced
osteolysis. Clin Orthop Relat Res 1992:7–18.
[24] Dannenmaier WC, Haynes DW,  Nelson CL.  Granulomatous
reaction and cystic bony destruction associated with high
wear rate in a total knee prosthesis. Clin Orthop Relat Res
1985;22:4–30.
[25] Kim JH,  Jung Y, Kim BS, Kim SH. Stem cell recruitment and
angiogenesis of neuropeptide substance P coupled with
self-assembling peptide nanofiber in a mouse hind limb
ischemia model. Biomaterials 2013;34:1657–68.
[26] Milz S, Putz R. Quantitative morphology of the subchondral
plate of  the tibial plateau. J Anat 1994;185:103–10.
[27] Gruhl S, Witte  F,  Vogt J, Vogt C. Determination of
concentration gradients in bone tissue generated by a
biologically degradable magnesium implant. J  Anal Atomic
Spectrom 2009;24:181–8.
[28] Niinomi M. Metals for biomedical devices. Elsevier; 2010.
[29] Rae T. The toxicity of metals used in orthopaedic prostheses.
An experimental study using cultured human synovial
fibroblasts. J  Bone Jt Surg Br Vol 1981;63:435–40.
[30] Saquib Q, Al-Khedhairy AA, Siddiqui MA, Abou-Tarboush
FM, Azam A,  Musarrat J. Titanium dioxide nanoparticles
induced cytotoxicity, oxidative stress and DNA damage in
human amnion epithelial (WISH) cells. Toxicol In Vitro
2012;26:351–61.
[31] He X, Hartlieb E, Rothmund L, Waschke J, Wu X, Van Landuyt
KL,  et al.  Intracellular uptake and toxicity of three different
titanium particles. Dent Mater 2015;31:734–44.
[32] Himmlova L, Dostalova T, Kacovsky A,  Konvickova S.
Influence of implant length and diameter on stress
distribution: a  finite element analysis. J Prosthet Dent
2004;91:20–5.
[33] Baggi L, Cappelloni I, Di Girolamo M, Maceri F, Vairo G. The
influence of implant diameter and length on stress
distribution of osseointegrated implants related to crestal
bone  geometry: a three-dimensional finite element analysis.
J  Prosthet Dent 2008;100:422–31.
[34] Prohaska T, Latkoczy C, Schultheis G, Teschler-Nicola M,
Stingeder G.  Investigation of Sr isotope ratios in prehistoric
human bones and teeth using laser ablation ICP-MS and
ICP-MS after Rb/Sr separation. J  Anal Atomic Spectrom
2002;17:887–91.
[35] Kang D, Amarasiriwardena D, Goodman AH. Application of
laser ablation-inductively coupled plasma-mass
spectrometry (LA-ICP-MS) to investigate trace metal spatial
distributions in human tooth enamel and dentine growth
layers and pulp. Anal Bioanal Chem 2004;378:
1608–15.
[36] Flatebo RS, Hol PJ, Leknes KN,  Kosler J, Lie SA,  Gjerdet NR.
Mapping of titanium particles in peri-implant oral mucosa
by  laser ablation inductively coupled plasma mass
spectrometry and high-resolution optical darkfield
microscopy. J  Oral Pathol Med 2011;40:412–20.
[37] Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent
internalization of particles via the pathways of clathrin- and
caveolae-mediated endocytosis. Biochem J  2004;377:159–69.
[38] Conner SD, Schmid SL. Regulated portals of entry into the
cell. Nature 2003;422:37–44.
[39] Kawaguchi H, Ogawa T, Shirakawa M, Okamoto H, Akisaka T.
Ultrastructural and ultracytochemical characteristics of
multinucleated cells after hydroxyapatite implantation into
rat  periodontal tissue. J  Periodontal Res 1992;27:48–54.
[40] Travlos GS. Histopathology of bone marrow. Toxicol Pathol
2006;34:566–98.
[41] Piattelli A, Piattelli M, Mangano C, Scarano A.  A  histologic
evaluation of eight cases of failed dental implants: is bone
overheating the most probable cause. Biomaterials
1998;19:683–90.
[42] Anazawa U, Hanaoka H, Morioka H, Morii T, Toyama Y.
Ultrastructural cytochemical and ultrastructural
morphological differences between human multinucleated
giant cells elicited by  wear particles from hip  prostheses and
artificial ligaments at the knee. Ultrastruct Pathol
2004;28:353–9.
7 Original works  
22 
 
7.1.2 Intracellular uptake and toxicity of three different Ti particles 
He X, Hartlieb E, Rothmund L, Waschke J, Wu X, Van Landuyt KL, Milz S, Michalke 
B, Hickel R, Reichl FX, Högg C. Dent Mater. 2015; 31(6):734-44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d e n t  a l m a t e r  i  a l s  3 1 (  2  0 1 5 )  734–744
Available  online  at www.sciencedirect.com
ScienceDirect
jo ur nal ho me  pag e: www.int l .e lsev ierhea l th .com/ journa ls /dema
Intracellular uptake and  toxicity of  three different
Titanium particles
Xiuli Hea,b,  Eva Hartlieb c,  Lena Rothmunda,b,  Jens Waschke c,  Xiao Wud,
Kirsten  L.  Van  Landuyt e,  Stefan Milz f,  Bernhard Michalkeg,
Reinhard Hickelb,  Franz-Xaver Reichla,b, Christof Högga,b,∗
a Department of Operative/Restorative Dentistry, Periodontology and Pedodontics, Ludwig-Maximilians-University
of Munich, Goethestr 70, 80336 Munich, Germany
b Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-University of Munich,
Nussbaumstr 26,  80336 Munich, Germany
c Institute of Anatomy and Cell Biology, Ludwig-Maximilians-University of Munich, Pettenkoferstr 11, 80336
Munich, Germany
d Helmholtz Zentrum München-German Research Center for Environmental Health, Cooperation Group of
Comprehensive Molecular Analytics, Ingolstädter Landstr 1, 85764 Neuherberg, Germany
e KU Leuven BIOMAT, Department of Oral Health Sciences, KU Leuven, Kapucijnenvoer 7, 3000 Leuven, Belgium
f Department of Anatomy II – Neuroanatomy, Ludwig-Maximilians-University of Munich, Pettenkoferstr 11, 80336
Munich, Germany
g Research Unit Analytical Biogeochemistry, Helmholtz Zentrum Munich-German Research Center for Environmental
Health (GmbH), Ingolstädter Landstr 1, 85764 Neuherberg, Germany
a  r t  i  c  l  e i n f  o
Article history:
Received 9 December 2014
Received in revised form
17  February 2015
Accepted 31 March 2015
Keywords:
Titanium
Nanoparticles
Cytotoxicity
Cellular uptake
DNA damage
a  b s t r  a  c t
Introduction. Titanium (Ti) and its  alloys are used for implants and other dental materials. In
this  study, cytotoxicity, DNA damage, cellular uptake and size of three kinds of Ti particles
were  measured.
Methods. Cytotoxicity for Ti microparticles (Ti-MPs, <44 m), NiTi microparticles (NiTi-MPs,
<44  m), and Ti nanoparticles (Ti-NPs, <100 nm) in periodontal ligament (PDL)-hTERT cells
was measured with XTT  test. DNA damage was determined with comet assay. Particle size
was measured with scanning electron microscope, intracellular uptake was determined
with laser scanning confocal microscopy and transmission electron microscopy.
Results.  The EC50 values of investigated particles were: 2.8 mg/ml (Ti-NPs), 41.8 mg/ml (NiTi-
MPs) and >999 mg/ml (Ti-MPs). The Olive Tail Moment (OTM) values at 1/10 EC50 were: 3.2
(Ti-NPs) and 2.2 (NiTi-MPs). An OTM of 2.2 for Ti-MPs was detected at the concentration of
6666  g/ml. Determined sizes of investigated particles were 20–250 nm (Ti-NPs), 0.7–90 m
(NiTi-MPs) and 0.3–43 m (Ti-MPs). The highest cellular uptake efficiency was observed with
Ti-NPs, followed by Ti-MPs and NiTi-MPs. Only Ti-NPs were found in the  nucleus.
∗ Corresponding author at: Department of Operative/Restorative Dentistry, Periodontology and Pedodontics, LMU Munich, Goethestr 70,
80336  Munich, Germany. Tel.: +49 89 2180 73842; fax: +49 89 2180  73841.
E-mail  address: christof.hoegg@lrz.uni-muenchen.de (C.  Högg).
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0109-5641/© 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
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Conclusion. Compared to Ti-MPs and NiTi-MPs, Ti-NPs induced higher cellular uptake effi-
ciency  and higher toxic potential in PDL-hTERT cells. Ni in the alloy NiTi induced an increase
in  the toxic potential compared to Ti-MPs.
© 2015 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
1.  Introduction
Titanium (Ti) and its alloys have been used as source mate-
rials for biomedical applications especially in dentistry, since
previous studies showed that these materials stand out for
good mechanical properties, excellent corrosion resistance
and high biocompatibility [1–4]. For example, it was  found
that Ti is one of the  most biocompatible metallic materials
because of its ability to form a  stable and insoluble protective
oxide layer (TiO2) on its surface [5,6]. Ti is preferentially used
for endosseous dental implant material [6]. Besides Ti, some
Titanium alloys are also used for  dental applications, such as
Nickel Titanium (NiTi). The alloy NiTi is used for castings of
crowns and denture construction, orthodontic archwires and
brackets [7,8].  Recently it has been found that the properties
of Ti implants can be improved by using nanostructured Ti
consisting of Ti-nanoparticles (Ti-NPs) [9].
Even though Ti based implants are considered to  be bio-
compatible, their induced side effects such as hypersensitivity
and allergic reactions have been reported [10–12].  It has
also been found that Ti based materials can cause immuno-
inflammatory reactions [13]. These side effects might have
been caused by the interaction between tissues and implants
[14,15]. Previous in vitro and in vivo studies showed that Ti
ions can be released from Ti based implants, for example by
corrosion, wear and electrochemical processes [16–20].  The
release of Ni ions from NiTi alloy also has been reported
[8]. Previous studies indicated that Ti ions and Ni  ions
induced cytotoxicity/DNA damage in human cells [21,22]. Fur-
thermore, Ti-particles/debris (3–250 m)  was found in the
peri-implant animal tissues after application of Ti based
implants [23,24]. Clinical studies also  showed that Ti parti-
cles in nanometer- and micrometer-size could be released into
human tissues/organs of the patients with Ti based implants
or replacements [21,25,26]. The toxic effect of Ti-particles has
been described in the literature: phagocytosis of Ti-particles
could induce cytotoxicity in  rat calvarial osteoblasts and MG63
cells [27,28];  Genotoxic effect of Ti-particles has also been
detected, which induced apoptosis in mesenchym stem cells
[29,30].
It was found that the particles size can influence the toxic-
ity of metal particles [31,32]. The ability of different particles
entering cells may  also affect the toxicity [31–33],  and it is
reported that particle size can impact the cellular uptake effi-
ciency and pathway [34–36].  There is less data about toxicity
and cellular uptake for Ti-NPs and Ti-MPs available.
The aim of this study is to compare the toxicity and
cellular uptake of nanometer-sized Ti,  micrometer-sized Ti
and NiTi particles, which can be released from dental
implants or replacements. In this study, Ti-NPs (Ti 98.5%,
<100 nm), Ti-microparticles (Ti-MPs) (Ti 99%, <44 m) and
NiTi-microparticles (NiTi-MPs) (Ni 30%, Ti 70% and <44 m)
were investigated. The cytotoxicity, genotoxicity, and cellu-
lar uptake efficiency of these investigated particles have been
measured in periodontal ligament (PDL) cells.
2.  Materials  and  methods
2.1.  Cell  culture
Clinically, PDL cells are the  cells growing around natural teeth,
which work as  the tooth anchor and sustain bone regeneration
[37].  PDL cells can provide the  implants with the same mobility
as  natural teeth and reduce the bone  loss around implants [38].
Therefore, dental implants combined with PDL would repre-
sent a great new therapeutic tool to  replace lost teeth [37,38].
Studies have demonstrated the PDL formation on the  surface
of Ti implants [37,39].
Periodontal ligament with lentiviral gene transfer of
human telomerase reverse transcriptase cells (PDL-hTERT
cells) were obtained from Experimental Surgery and Regener-
ative Medicine, Department of Surgery, Ludwig-Maximilians-
University (LMU), Munich, Germany [40].  The reason why
PDL-hTERT cells were used is  that PDL-hTERT cells have
extended lifespan with identical morphology compared to
the primary PDL cells [40].  The extended lifespan is of great
importance to the  PDL engineering. PDL-hTERT cells were
cultured in a  250 ml  tissue culture flask (BD falcon, Franklin
Lakes, USA) at 37 ◦C and 100% humidity with 5% CO2. The VLE
(very low endotoxin) Dulbecco’s Minimum Essential Medium
(MEM) with 4.5 g/l d-Glucose (Biochrom, Berlin, Germany) was
supplemented with 1% penicillin/streptomycin (Biochrom,
Berlin, Germany) and 10% Fetal Bovine Serum (Sigma–Aldrich,
Munich, Germany).
2.2.  Particle  exposure  and  size  measurement
Ti-MPs (99%; <44 m (−325 mesh)) and NiTi-MPs (70% Ti,
30% Ni; <44  m (−325 mesh)) were obtained from Alfa Aesar,
Karlsruhe, Germany. Ti-NPs contained 98.5% Ti < 100 nm
(Sigma–Aldrich, St. Louis, USA). Fresh suspensions of Ti-MPs,
NiTi-MPs and Ti-NPs were prepared for  each experiment. The
stock solutions were prepared by adding investigated parti-
cles (1000 mg  Ti-MPs, 150 mg NiTi-MPs, and 21.8 mg  Ti-NPs)
into 3 ml  of medium and well mixed. To determine the exact
concentrations of particles, 200 l of stock solution was  evapo-
rated at 70 ◦C to complete dryness and the average net weight
of the particles was measured six  times. The final expo-
sure concentrations (particle weight/0.1 ml)  were obtained by
adding different volumes of stock solution. The exposure
concentrations of the investigated particles for each test are
shown in  Table 1.
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Table 1 – Concentrations of Ti-MPs, NiTi-MPs and Ti-NPs used in XTT viability assay, trypan blue test and comet assay.
XTT viability assay (g/ml) Trypan blue test (g/ml) Comet assay (g/ml)
Ti-MPs NiTi-MPs Ti-NPs Ti-MPs NiTi-MPs Ti-NPs Ti-MPs NiTi-MPs Ti-NPs
999,000 83,400 13,080  33,300 20,900 1420 6666  4180 284
300,000 55,600 4360 6660 4180 284 3333  836 57
103,000 16,680 1308 3330 836 56 666 418 28
33,000 5560  436 666 418 28 333 209 14
1670 131
The size of investigated particles was determined with
Scanning Electron Microscopy (SEM) LEO 1550 (Zeiss,
Oberkochen, Germany) by measuring the minimal Feret
distance [41]. 4× 200 single particles of each investigated
particle sample were used for particle size measurement. In
case of spontaneous combustion Ti-NPs were suspended in
PBS (phosphate buffered saline) before measurement.
2.3.  XTT  viability  assay
XTT-based cell viability assay was applied to determine
the half-maximum effect concentration (EC50)  values for
the investigated particles in PDL-hTERT cells. In this assay,
a concentration of 20,000 cells/well (in 0.1 ml  medium)
was incubated for 24 h in the 96-well plate (BD falcon,
Heidelberg, Germany). Then the  cells were treated with
different concentrations (Table 1) of Ti-NPs, Ti-MPs and
NiTi-MPs. Negative control cells received medium only.
Positive control cells received 1% Triton X-100. After expo-
sure of cells to investigated particles for 24  h, 50 l  XTT
(1 mg/ml) solution (sodium 30-[1-(phenyl-aminocarbonyl)-
3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene sulfonic acid
hydrate) labeling agent (in RPMI (Roswell Park Memorial Insti-
tute medium) 1640 without phenol red) and electron-coupling
reagent PMS  (N-methyldibenzopyrazine methylsulfate in PBS)
(0.383 mg/ml) were added (cell proliferation kit II; Roche Diag-
nostics GmbH Penzberg, Germany). After 4 h incubation the
photometric analysis was performed in another well plate to
determine formazan values.
The formazan values were referred to positive and neg-
ative control. EC50 values were obtained by fitting the data
to a dose–effect sigmoidal curve using GraphPad prism 4
(GraphPad Software, Inc. La Jolla, USA). Each experiment was
repeated four times (n  = 4).
2.4.  Cell  death  detected  with  trypan  blue  staining
Trypan blue staining reveals the ratio of live and dead cells.
Non-viable cells are stained blue since the cell membrane of
non-viable cells is permeable for trypan blue [42].  The cells
were treated with different concentrations (Table 1)  of inves-
tigated particles for 24  h. After the  treatment, the cells were
washed three times with PBS. To detach cells from the 12-well
plate, the cells were treated with trypsin at 37 ◦C for 5 min.
The trypsin effect was stopped by adding medium. After-
wards, the cells were stained with 0.4% trypan blue (Sigma
Aldrich, Steinheim, Germany) for 3 min. Ratio of dead cells
was counted in neubauer chamber (Paul Marienfeld Lauda-
Königshofen, Germany) (100–120 cells). Negative control cells
received medium only. Each experiment was repeated three
times (n = 3).
2.5.  Comet  assay
DNA damage of investigated particles was analyzed by the
alkaline single-cell microgel electrophoresis (comet) assay.
This comet assay method has been described in our previous
studies [42,43]. Experiment was conducted in  red light. Slides
(26 mm ×  76  mm,  R. Langenbrinck, Emmendingen, Germany)
were coated with a  layer of 85 l 0.5% agarose (Biozym, Olden-
dorf, Germany), and then dried for one week at 25 ◦C excluding
daylight.
PDL-hTERT cells (2 × 105)  were cultured in 1 ml  medium
in a  12-well plate (BD falcon, Heidelberg, Germany) for 24 h.
Afterwards, the cells were exposed to different concentrations
(Table 1) of all investigated particles for further 24 h.  Then cells
were washed with 1 ml  PBS three times, and treated with 100 l
trypsin at 37 ◦C for 5 min, 300 l  medium was added to  stop the
effect of trypsin. The cell suspension was then centrifuged
(800 rpm, 10 min), and the  supernatant was discarded. The
cell pellets were re-suspended in 400 l PBS and centrifuged
again. Cell pellets were suspended in  25 l PBS, and mixed with
75 l  LMP-Agarose (low melting point) (Biozym, Oldendorf,
Germany), and then transferred onto the pre-coated slides (as
described above). A  covering glass (24 mm  × 60 mm) (R. Lan-
genbrinck, Emmendingen, Germany) was placed on the top of
the slide. The slide was then kept at 4 ◦C for at least 5 min, and
another layer of agarose was  over stacked. After incubation at
4 ◦C for 5  min, the covering glass was  removed, and the  slide
was  stored in  lysis buffer (2.5 M NaCl, 100 mM  EDTA, 10 mM
Tris, 1% Na-lauroylsarcosinate, H2O; pH = 10;  before use 1% Tri-
ton X-100 and 10% dimethylsulfoxide were added) overnight.
Before electrophoresis, the slides were placed in the alka-
line electrophoresis solution (6 ◦C) for 30  min. Electrophoresis
was conducted at 6 ◦C with 25 V, maximum 300 mA for 30 min.
The slides were then washed with 400 mM Tris buffer (Merck,
Darmstadt, Germany) and stained with 50  l 200 g/ml ethid-
ium bromide (Sigma–Aldrich, St. Louis, USA). The slides were
evaluated using an Olympus BX 60 fluorescence microscopy
(Olympus, Hamburg, Germany) with a  40×  objective and
the software program comet assay II (Perceptive Instrument
Ltd., Haverhill, UK). Positive control cells received 100 M
methyl methanesulfonate (MMS) (Sigma–Aldrich, Steinheim,
Germany) and negative control cells received medium only.
For each sample, about 50 cells were investigated. The test
was repeated six times (n  = 6). Olive tail moment (OTM) as
a  product of the  tail length and the percentage of total
DNA in the tail was applied to evaluate DNA damage
[42,43].
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2.6.  Cellular  uptake
2.6.1.  Laser  scanning  confocal  microscopy  (LSCM)
measurement
Cellular and intracellular uptake of Ti-NPs, Ti-MPs and NiTi-
MPs in PDL-hTERT cells was  determined with LSM 510
(Zeiss, Oberkochen, Germany), as described in a  previous
study [44]. It was found that noble metals can be used
as marker for cellular imaging of LSCM due to their sur-
face plasmon resonance [45,46]. Similarly, Ti-NPs, Ti-MPs
and NiTi-MPs also emit intensive light in a  close proxim-
ity to the wavelength (633 nm)  of the laser. The nucleus
was stained with Sybr green I nucleic acid gel  stain (Invitro-
gen, Oregon, USA). For visualization of the cells the plasma
membrane was stained with cell mask membrane plasma
orange stain (Invitrogen, Oregon, USA). Sybr green I and cell
mask membrane plasma orange were excited by 488 nm and
543 nm.
The cells were cultured for 24 h on a  covering glass in 24-
well plate (BD Falkon, Franklin lakes, USA) and then exposed
to Ti-NPs (28 g/ml (1/100 EC50), 56 g/ml (1/50 EC50)), NiTi-
MPs  (418 g/ml (1/100 EC50), 4180 g/ml (1/10 EC50)) and Ti-MPs
(418 g/ml) for another 24  h. After that, the cells were care-
fully shaken, washed with PBS three times and stained with
2.5 g/ml of Cell Mask Membrane Plasma Orange at 37 ◦C
for 5 min. The cells were then fixed with 2% paraformalde-
hyde (Carl Roth, Karlsruhe, Germany), washed three times
with PBS, and stained with Sybr green I (1:50,000) at 25 ◦C for
15 min. The covering glasses were mounted on microscopic
slides using prolong gold antifade reagent with 4′,6-diamidin-
2-phenylindol (DAPI) (Invitrogen, Oregon, USA) after they were
washed three times with PBS. Samples were kept at 4 ◦C before
analysis. With  the LSCM, a  stack of images at different points
along the Z-axis was  performed in  the direction away from the
cover slip and moving into the cells. For each experiment about
60 cells were investigated and the experiment was repeated
four times (n = 4).
2.6.2.  Transmission  electron  microscopy  (TEM)
measurement
TEM Libra 120 (Zeiss, Oberkochen, Germany) was  used to
confirm the cellular uptake of Ti-NPs. Ti-MPs and NiTi-MPs
were not investigated due to the technical difficulties obtain-
ing  ultra thin sections from large particles. PDL-hTERT cells
were treated with Ti-NPs (28 g/ml) for 24  h. After the incu-
bation with Ti-NPs, the cells were washed with PBS three
times and fixed with 2% glutaraldehyde in 0.1 M PBS buffer
at 25 ◦C for at least 2  h. Fixed cells were washed with PBS
three times and then treated with 1% osmium tetroxide
(Merck, Darmstadt, Germany) at 25 ◦C for 1 h. The dehydra-
tion was performed with ascending concentrations of ethanol:
30%, 50%, 70%, 90% and 100% (ethanol purity ≥  99.8%, Carl
Roth, Karlsruhe, Germany). Afterwards, cells were embed-
ded in epon 812 (Serva, Heidelberg, Germany). After the resin
blocks were hardened, they were cut into ultra thin sec-
tions (70–90 nm)  with an  ultra-microtome (Zeiss, Oberkochen,
Germany), and then contrasted with 2% uranyl acetate
(Merck, Darmstadt, Germany) followed by Pb-citrate (Merck,
Darmstadt, Germany). The ultra thin sections were ana-
lysed.
To obtain morphology and size, suspensions of Ti-NPs in
water were evaporated to dryness on TEM grids and observed
with TEM.
2.7.  Statistic  analysis
The results were presented as mean ±  standard deviation (SD).
To analyze the effect of particles on cytotoxicity, DNA dam-
age, and cellular uptake, a one-way ANOVA analysis followed
by Tukey’s test was applied. Differences were considered sta-
tistically significant only when the p-value was  less than 0.05
(p < 0.05) [47].
3.  Result
3.1.  Particle  size  measurement
It was found that about 90% of Ti-NPs were sized below 100 nm
and 0.6% of Ti-NPs were sized above 200 nm. Ti-MPs were sized
between 0.3 m and 43 m; more  than 50% of the particles
were sized below 5 m. NiTi-MPs were sized between 0.7 m
and 90 m, 60% of the particles were sized above 10 m and
17% of small particles were sized below 5 m. The particle size
distributions of all investigated particles are shown in Table 2.
3.2.  Cytotoxicity
3.2.1.  XTT  viability  assay
The EC50 values for Ti-NPs, Ti-MPs and NiTi-MPs in  PDL-
hTERT cells were determined and a  relative toxicity was
calculated (Table 3). Ti-NPs had the highest toxic potential
(EC50 =  2.84 ± 0.37 mg/ml; mean ± SD, n = 4). EC50 value of NiTi
was 41.8 ± 4 mg/ml  (mean ±  SD, n  = 4). EC50 value for Ti-MPs
could not be  determined at the  concentration <999 mg/ml and
no higher concentrations of Ti-MPs were used.
3.2.2.  Cell  death
Compared to the medium (including 6% dead cells), Ti-NPs
caused 9% and 19% increase in cell death at the concentra-
tion of 284 g/ml (1/10 EC50,  p < 0.01) and 1420 g/ml (1/2 EC50,
p < 0.001), respectively. There is no significant difference for Ti-
NPs at the  lower concentrations 1/50 and 1/100 EC50 compared
to medium.
NiTi-MPs induced 9% more  cell death (p < 0.01) at the con-
centration of 20,900 g/ml (1/2 EC50) compared to medium. No
significant difference was  found at 1/10 EC50,  1/50 EC50 and
1/100 EC50.
Ti-MPs only caused 9% increase (p < 0.05) of dead cells at the
highest concentration (33,300 g/ml) compared to medium. No
significant difference was found at lower concentrations.
3.3.  DNA  damage
Comet assay results for Ti-NPs, Ti-MPs and NiTi-MPs in PDL-
hTERT cells are shown in Fig. 1.
A significant increase in OTM value (compared to negative
control) was detected after Ti-NPs exposure at all concentra-
tions (p < 0.01). The mean OTM value for Ti-NPs at 1/10 EC50
(284 g/ml) was  significantly higher compared to 1/50 EC50,
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Table 2 – Particle size distributions of Ti-NPs, NiTi-MPs and Ti-MPs (mean ± SD).
Particles Particle size distribution (%)
Ti-NPs
20–50  nm 50–100 nm 100–200 nm >200 nm
16.5 ± 4.9 73.1 ±  4.2 9.8  ± 1.7 0.6 ± 0.25
NiTi-MPs
<1 m 1–5  m 5–10 m >10 m
4.38 ± 0.75 12.50 ± 2.7  22.50  ± 3.0 60.60 ± 3.6
Ti-MPs
<1 m 1–5  m 5–10 m >10 m
11.63 ±  0.63 42.25 ± 2.99 24.5 ±  0.91 20.38 ± 2.02
Fig. 1 – Comet assay result for Ti-NPs, NiTi-MPs and Ti-MPs. *Significantly different (p < 0.05) to negative control (medium).
1/100 EC50 and 1/200 EC50 (p < 0.01). No significant difference
was detected among 1/50 EC50, 1/100 EC50 and 1/200 EC50.
A significant increase in OTM value (p < 0.001) was observed
at the concentration of 4180 g/ml (1/10 EC50)  after NiTi-MPs
exposure compared to negative control. Ti-MPs induced a  sig-
nificant increase in  OTM value (p < 0.001) at the  concentration
of 6666 g/ml, but no significant difference at the lower con-
centrations (3333 g/ml, 666 g/ml and 333 g/ml).
In addition, the OTM value of Ti-NPs at the  concentration
of 284 g/ml (1/10 EC50) was 1.5 times higher than OTM value
of NiTi-MPs at the concentration of 4180 g/ml (1/10 EC50).
284 g/ml (1/10 EC50) of Ti-NPs induced a significantly higher
OTM value compared to Ti-MPs at 6666 g/ml (p < 0.001).
3.4.  Cellular  uptake
3.4.1.  LSCM  measurement
Ti-NPs could be  detected in the cytoplasm and nucleus of PDL-
hTERT cells (Fig. 2). For NiTi-MPs and Ti-MPs, particles around
1 m were found in the PDL-hTERT cells. No particles were
detected in the nucleus (Figs. 3 and 4).
Table 3 – EC50 values (mean ± SD) and relative toxicity of
Ti-NPs, NiTi-MPs and Ti-MPs determined with XTT
viability assay.
EC50 (mg/ml) Relative toxicity
Ti-NPs 2.84 ± 0.37 352
NiTi-NPs 41.8 ± 4  24
Ti-MPs >999 1
The cellular uptake efficiency of Ti-NPs, Ti-MPs and NiTi-
MPs was  determined by LSCM with different concentrations,
as  shown in Table 4.  The ratio of cells with Ti-NPs inside the
cytoplasm significantly increased (p  < 0.05) when the expo-
sure concentration of Ti-NPs was raised from 28  g/ml (1/100
EC50)  to 56  g/ml (1/50 EC50). The ratio of cells with Ti-NPs
in the nucleus also increased significantly from 5.0 ± 1.5%
(mean ±  SD, n  = 4) to  11% ± 1.3% (mean ±  SD,  n  = 4) when
the concentration was increased. For NiTi-MPs, no signifi-
cant difference was found in the cellular uptake efficiency
when the exposure concentration was  increased from 418
to 4180 g/ml. For Ti-MPs (418 g/ml), 33% ± 4.5% (mean ±  SD,
n = 4) of detected cells were found with Ti-MPs in the cyto-
plasm.
Table 4 – Cellular uptake efficiency of Ti-NPs, NiTi-MPs
and Ti-MPs.
Ratio of
cells  with
particles in
cytoplasm
Ratio of
cells  with
particles in
nucleus
Ti-NPs
28 g/ml (1/100 EC50) 58% ± 3.6 5.0% ± 1.5
56 g/ml (1/50 EC50)  66% ± 3.0 11% ± 1.3
NiTi-MPs
418 g/ml  (1/100 EC50)  11% ± 2.0 0%
4180 g/ml (1/10 EC50) 10% ± 0.8 0%
Ti-MPs
418 g/ml  33% ± 4.5 0%
d  e n t a  l m a  t e r  i  a l  s  3 1  (  2  0  1 5 )  734–744 739
Fig. 2 – (a) LSCM image of a PDL-hTERT cell after exposure to Ti-NPs (28 g/ml) for 24 h (z-stack slices merged into one
image). Ti-NPs: pink, cell plasma membrane: blue, nucleus: green, yellow arrow: Ti-NP in the nucleus. (b) LSCM image of the
nucleus of the same cell in (a). Ti-NPs: pink, nucleus: green, yellow arrow: Ti-NP in the nucleus. (For interpretation of the
references to  color in this figure legend, the reader is referred to  the web version of this article.)
3.4.2.  TEM  measurement
The cellular uptake of Ti-NPs in PDL-hTERT cells was con-
firmed with TEM (Fig. 5). After exposure to 28  g/ml (1/10 EC50)
of Ti-NPs for 24 h, particles between 30 nm and 200 nm were
detected inside the cytoplasm.
Particle morphology of Ti-NPs in Fig. 6 shows that Ti-
NPs can agglomerate, so particles/agglomerates with a  size of
20–250 nm were observed.
4.  Discussion
In this study, the toxic potential of Ti-NPs, Ti-MPs and NiTi-MPs
in PDL-hTERT cells was measured and compared according to
their particle size and cellular uptake efficiency.
4.1.  Particle  size  measurement
According to  the  manufacturer, Ti-MPs and TiNi-MPs have a
particle size below 325 mesh, this corresponds to a  particle
size of below 44  m, and Ti-NPs have a  particle size below
100 nm.  Analysis of Ti-MPs with SEM verified stated data of
manufacturer, while analysis of NiTi-MPs showed around 1%
of particles with a  size above 44 m. There is no explana-
tion in literature for the  existence of these larger particles.
Analysis of Ti-NPs also disagreed with manufacturer’s data.
SEM-measurement showed that besides Ti-NPs below 100 nm,
Ti particles/agglomerates sized above 100 nm were found. For
measurement of intracellular uptake of Ti-NPs, dimensions of
particles were checked again with TEM: Results also showed
agglomeration of particles resulting in sizes above 100 nm.  In
previous studies it was  described that agglomeration is a com-
mon  property of nanoparticles, which is due to  the cohesive
forces between primary nanoparticles [48].  For other materials
(e.g. CuO, AgO, TiO2, Cu, Al, Al2O3)  studies showed that metal
and metal oxide nanoparticles tend to form large agglomer-
ates above 100 nm in liquid medias [31,49].
Clinical studies indicated that particles of Ti and Ti alloys
ranging from 0.01 m to 50 m can be released into human
body from Ti-based implants or replacements [25,26] and ani-
mal studies demonstrated the presence of Ti particles/debris
sized between 3 m  and 250 m in the peri-implant bone or
tissues [23,24].  The particle sizes of our investigated particles
are in that range.
4.2.  Cytotoxicity:  XTT  assay  and  cell  death
It was  reported that Fe2O3-,  Fe3O4- and TiO2-NPs showed
no significantly different cytotoxicity compared to their cor-
responding MPs in A549 cells at the same concentration
(40 g/cm2) [31].  However, it was found that CuO- and ZnO-
NPs induced higher cytotoxicity than their corresponding MPs
[31,32]:  CuO-NPs showed a 2-fold increase of cytotoxicity in
A549 cells compared to CuO-MPs at the same concentration
(40 g/cm2) (trypan blue exclusion test) [31];  after exposure to
Fig. 3 – LSCM image of a PDL-hTERT cell after exposure to
NiTi-MPs (418 g/ml) for 24 h (z-stack slices merged into
one image). NiTi-MPs: pink, cell plasma membrane: blue,
nucleus: green, yellow arrow: NiTi-MP in the cell. (For
interpretation of the references to  color in this figure legend,
the reader is referred to the web version of this article.)
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Fig. 4 – LSCM image of a PDL-hTERT cell after exposure to Ti-MPs (418 g/ml) for  24 h (z-stack slices merged into one image).
Ti-MPs: pink, cell plasma membrane: blue, nucleus: green, yellow arrow: Ti-MP in  the cell. (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of this article.)
50 g/ml of ZnO-NPs within 24 h, MTT  (3-[4,5-dimethylthiazol-
2-yl]-2,5 diphenyl tetrazolium bromide) assay and trypan blue
exclusion test results indicated that around 50%  of human
nasal mucosa cells lost viability, whereas no loss of viability
was detected for ZnO-MPs at the same concentration [32].  Fur-
thermore it has been discussed that cytotoxicity of NPs can be
induced by their large surface area per  mass, release of toxic
ions and ability to pass the  cell membrane [32,50].  The results
for cytotoxicity of Fe2O3-, Fe3O4- and TiO2-particles might be
explained by the fact that MPs  used in the study above were
mainly ≤1 m and so could be  taken up by cells just as  their
corresponding NPs. But particle sizes of CuO-MPs, ZnO-MPs
(>1 m)  used in the study cited above are comparable to Ti-MPs
investigated in  present study.
XTT test and trypan blue exclusion test were used to
measure the cytotoxicity of Ti-NPs, Ti-MPs and NiTi-MPs in
PDL-hTERT cells. The results of XTT test indicated that the
EC50 value of Ti-NPs (2.84 mg/ml) was more than 350-fold
lower than the EC50 of  Ti-MPs (>999 mg/ml). Therefore, Ti-NPs
induced higher cytotoxicity than Ti-MPs, which is also con-
firmed by the trypan blue exclusion test:  a  significant increase
in nonviable cells was observed after exposure to 0.28 mg/ml
of Ti-NPs; 120-fold of this concentration (33.3 mg/ml) was
required for Ti-MPs to get the same effect as after Ti-NPs
exposure. So  the present study for Ti-NPs and Ti-MPs is in
accordance with the findings cited above, in which CuO- and
ZnO-NPs caused higher cytotoxicity than their corresponding
MPs [31,32].
4.3.  DNA  damage
In the present study, comet assay results indicated that
14 g/ml of Ti-NPs induced a  1.5-fold increase in  OTM value
compared to negative control in PDL-hTERT cells; while a 500-
fold concentration (6666 g/ml) was  required for Ti-MPs to get
the same extent of DNA damage as after Ti-NPs exposure. The
increase in  OTM value is considered to be an indicator of DNA
damage [42,43]; therefore, Ti-NPs displayed a  500-fold higher
Fig. 5 – (a) TEM image of a PDL-hTERT cell after exposure to Ti-NPs (28 g/ml) for 24 h. (b) Magnification of the marked area
in (a). Yellow arrow: Ti-NPs (black) in the cell. (For interpretation of the references to color in this figure legend, the reader is
referred to the web version of this article.)
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Fig. 6  – TEM image of Ti-NPs (agglomeration).
DNA  damage potential compared to  Ti-MPs. On the contrary,
in previous studies Fe2O3 and TiO2-NPs caused significantly
(p <  0.05) less DNA damage (5% less in tail) compared to the
corresponding MPs  at the same concentrations [31].  But it was
also described that NPs such as  ZnO or CuO, induced more
DNA damage than their corresponding MPs: ZnO-NPs induced
a significant increase in  DNA damage in human nasal mucosa
cells starting from the concentration of 10 g/ml (p < 0.05), in
comparison to the negative control, while no DNA damage
was observed with ZnO-MPs at the same concentration [32];  a
4-h exposure to CuO-NPs (40 g/cm2) induced 4 times more
DNA damage in  A549 cells compared to  the control group,
same concentration of CuO-MPs only caused 0.5-fold more
DNA damage [31].  So in the  present study the  results for Ti
particles agree with the results cited above for ZnO and CuO.
4.4.  Cellular  uptake
In the present study, LSCM results showed that after expo-
sure to Ti-NPs (28 g/ml), about 60% of investigated cells
were found containing Ti-NPs. Therefore, Ti-NPs had the
highest cellular uptake efficiency, compared to Ti-MPs and
TiNi-MPs. The higher cellular uptake efficiency of Ti-NPs
compared to Ti-MPs indicates that the uptake of Ti parti-
cles in PDL-hTERT cells is also size-dependent. This result
for Ti-NPs is in line with previous studies. These former
studies reported that non-phagocytic eukaryotic cells could
take up particles that are below 1 m [51], and the cellular
uptake efficiency of nanoparticles can be  affected by parti-
cle size [35,36,52]: the intracellular uptake efficiency of silica
nanoparticles for Hela cells is  size dependent in the order of
55.64 nm > 167.84 nm > 307.6 nm [35]. The intracellular uptake
efficiency of gold NPs in human breast cancer SK-BR-3 cells
was also influenced by the  particle size, a maximal uptake
was mediated by particles of 40–50 nm [36].  It was found that
poly (lactic-co-glycolic acid) (PLGA) particles in size of 100 nm
induced 1.7 and 5.8 times higher uptake efficiency compared
to 1  m- and 10 m-PLGA particles in  Caco-2 cells, respectively
[52].
In the present study, in  addition to the  detected highest
cellular uptake efficiency, the highest cytotoxicity was also
determined for Ti-NPs compared to Ti-MPs and NiTi-MPs. Sim-
ilar result has been reported by a  previous study, where toxicity
of Silica-Titania Hollow NPs (SiTi-NPs) in macrophages has
been correlated to  the cellular uptake efficiency: cationic SiTi-
NPs (50 nm) induced the highest uptake efficiency and also the
most toxic effects (e.g. cytotoxicity) on macrophages J774A.1
cells compared to  other SiTi-NPs with different sizes and coat-
ing surfaces [35].  Furthermore, results of present study showed
that only Ti-NPs were found in the nucleus and Ti-NPs induced
more  DNA damage compared to Ti-MPs and NiTi-MPs. So
the higher potential of DNA damage for NPs might also be
explained by the nuclear uptake of NPs.
Particles can be taken up by cells via endocytosis which
includes phagocytosis and pinocytosis [53]. Through phago-
cytosis, large particles with diameters exceeding 750 nm can
be taken up, but it occurs only in specific cells such as
macrophages, neutrophils and monocytes [53].  Pinocytosis
occurs in all cell types and four mechanisms of pinocy-
tosis were reported: macropinocytosis (vesicle size >1 m),
clathrin-mediated endocytosis (vesicle size is  around 120 nm),
caveolae-mediated endocytosis (vesicle size is 60 nm)  and
clathrin- and caveolae-independent endocytosis (vesicle size
is 90 nm)  [53,54].  A previous study showed that silica par-
ticles (307.6 nm)  were taken up by Hela cells mainly via
clathrin-mediated endocytosis [35],  although this particle size
742  d e n t a l m  a t  e r  i a  l s 3  1 (  2 0 1  5  )  734–744
(307.6 nm)  is  2.5 times larger than the vesicle size (120 nm)  of
clathrin-mediated endocytosis. It was found that smaller sil-
ica particles (56 nm)  can also be taken up by caveolae mediated
endocytosis (60 nm) except by clathrin-mediated endocyto-
sis (120 nm)  [35].  In the present study, for Ti-MPs no EC50
could be determined at the concentration of 999 mg/ml, so
cellular uptake efficiency of Ti-MPs at different concentra-
tions was not compared. The cellular uptake efficiency of
the Ti-NPs increased by 8% when the exposure concentra-
tion was improved from 28 g/ml to 56  g/ml, but the cellular
uptake efficiency of NiTi-MPs did  not significantly increase
even when the exposure concentration was  increased from
418 g/ml to 4180 g/ml. Obviously, Ti-NPs and NiTi-MPs can
be taken up  through different uptake mechanisms: with the
size of 20–250 nm,  Ti-NPs could be taken up by both caveolae
mediated endocytosis (60 nm)  and clathrin-mediated endocy-
tosis (120 nm); NiTi-MPs (0.7–90 m)  might be taken up  by the
clathrin-mediated endocytosis (120 nm).
In the present study, after PDL-hTERT cells were exposed
to Ti-NPs (20–250 nm), about 4 to 15-times larger Ti particles
with a size between 0.3 and 1 m were found in the nucleus.
Similarly, Cronholm et  al. reported that after exposure to Ag-
NPs (20–200 nm), particles between 0.5 and 1 m were detected
in the nucleus of A549 cells [44].  It  was  reported that the
nuclear bidirectional transport of macromolecules between
the nucleus and the cytoplasm could occur through the
nuclear pore complexes (NPCs) with a  diameter of 40–50 nm
[55,56]. It was  found that macromolecules such as  cargo-
receptor-gold complexes with a  diameter up  to 40 nm were
able to be transported through NPCs [55].  Considering the lit-
erature cited above [55,56], in the present study Ti particles
(0.3–1 m) found in the nucleus are too large to  be transported
through NPCs. Additionally, it was found that Ti-NPs can form
agglomerates larger than 100 nm (Fig. 6). Two explanations
for finding such large Ti particles in the nucleus might be
given: (1) the larger particles (0.3–1 m)  in the nucleus might
be agglomerates formed by each Ti-NP (20–50 nm) that is able
to go through nuclear pores; (2) the agglomeration of Ti-NPs
occurs in the cytoplasm and then the agglomerates are trans-
ported into the nucleus via vesicles lodged to the nucleus. The
second explanation is  in accordance with previous study on
Ag-NPs suggesting also that Ag-NPs can be transported with
vesicles [54].
In the present study, NiTi-MPs (EC50 =  42 mg/ml) medi-
ated more  than 24-times cytotoxicity compared to Ti-MPs
(EC50 >  999 mg/ml). Considering the size distribution of NiTi-
MPs  and Ti-MPs (Table 2), 17%  of NiTi-MPs were below 5 m,
while 54% of Ti-MPs were below 5 m, and meanwhile, Ti-MPs
induced 2-fold higher cellular uptake efficiency, this higher
cytotoxicity (24-fold) of NiTi could be  explained by the toxic
potential of Ni. In previous studies, the  adverse effects of
Ni have been reported: Ni is not only known as  an  allergen
but also a possible immunotoxic agent in humans [57,58] and
it  was  found that Ni  (2.5 ng/ml) released from Ni-containing
fixed orthodontic appliances could cause cytotoxicity and
DNA damage in oral mucosa cells [22]. Therefore, the toxic
effects of investigated particles (Ti-NPs, Ti-MPs and NiTi-MPs)
might depend not only on the particle size and cellular uptake
efficiency, but also on the chemical composition such as  the
alloy NiTi.
5.  Conclusion
Compared to  Ti-MPs and NiTi-MPs, Ti-NPs induced higher
cellular uptake efficiency and higher toxic potential in PDL-
hTERT cells. Ni in the alloy NiTi induced an increase in the
toxic potential compared to Ti-MPs.
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